Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

I9_DISVEINLYMPH

vascular disease: A non-neoplastic or neoplastic disorder affecting the arteries, veins, or lymphatic vessels. Examples include vasculitis, thrombophlebitis, arteriosclerosis, lymphedema, hemangioma, and angiosarcoma.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints I9_PHLETHROM I9_PHLETHROMBDVTLOW I9_PVT I9_THROMBOTH I9_VARICVE I9_VARICVEOES I9_VARICVESOTH I9_VEINSOTH I9_LYMPHADE I9_LYMPHOTH	70004
6. Filter based on genotype QC (FinnGen only)	70004

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	I9_DISVEINLYMPH
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	I9_PHLETHROM\|I9_PHLETHROMBDVTLOW\|I9_PVT\|I9_THROMBOTH\|I9_VARICVE\|I9_VARICVEOES\|I9_VARICVESOTH\|I9_VEINSOTH\|I9_LYMPHADE\|I9_LYMPHOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Cardiovascular diseases

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	600788	400004	196249
Only index persons	501928	341484	160444
Unadjusted period prevalence (%)
Whole population	9.45	11.46	5.48
Only index persons	10.50	12.55	6.12
Median age at first event (years)
Whole population	50.16	48.61	53.16
Only index persons	48.06	46.61	51.14

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	70004	46375	23629
Unadjusted period prevalence (%)	13.99	15.81	10.42
Median age at first event (years)	47.91	44.55	54.52

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
32544: Matched controls
243248

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C03CA01

ATC

furosemide; systemic

2.0

323.0

7983

34214

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.8

323.0

1926

3924

PHG76

NOMESCO Finland

Intraluminal laser vein occlusion of long saphenous vein

+∞

323.0

389

M79.6

ICD-10 Finland

Pain in limb

1.9

323.0

10383

47885

I80.20

ICD-10 Finland

Phlebitis and thrombophlebitis in the iliac vein

484.3

323.0

385

PHM79

NOMESCO Finland

Endovenous obliteration of v.saphena anterior

3030.5

323.0

408

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

65.5

323.0

3037

382

R60.0

ICD-10 Finland

Localized oedema

2.9

323.0

3470

9478

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

72.9

323.0

1657

179

I83

ICD-10 Finland

Varicose veins of lower extremities

18.7

323.0

1338

557

4511A

ICD-9 Finland

Phlebitis and thrombophlebitis, Of deep vessels of lower extremities

+∞

323.0

733

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

92.7

323.0

1367

115

PHD99

NOMESCO Finland

Resection of other vein

3809.8

323.0

6334

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

50.0

323.0

3093

510

K94

ICPC

Phlebitis/thrombophlebitis

15.4

323.0

845

420

28920

ICD-8 Finland

Other disease of blood and blood-forming organs, Nonspecific mesenteric lymphadenitis

+∞

323.0

770

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

13.2

323.0

1137

667

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

52.5

323.0

1478

220

I86.1

ICD-10 Finland

Scrotal varices

39.9

323.0

884

170

B01AA03

ATC

warfarin; systemic

3.1

323.0

8074

23405

4549X

ICD-9 Finland

Varicose veins of lower extremities, Without mention of ulcer or inflammation

+∞

323.0

2431

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

70.1

323.0

1105

122

A46

ICD-10 Finland

Erysipelas

2.5

323.0

4761

15813

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

61.9

323.0

1546

196

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

8014.1

323.0

3825

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

+∞

323.0

2432

PHM99

NOMESCO Finland

Endovenous obliteration of other vein

2096.8

323.0

1647

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

1008.0

323.0

788

K95

ICPC

Varicose veins of leg

20.8

323.0

759

279

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

10.7

323.0

2820

2145

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

130.7

323.0

9347

748

PHD77

NOMESCO Finland

Resection of short saphenous vein

+∞

323.0

563

5611

FHL

Vena saphena Magna and / or swarm of nodule and possible local emissions

2009.0

323.0

2080

TPH10

NOMESCO Finland

Sclerotherapy of varicose veins

406.9

323.0

431

5612

FHL

Local excisions and / or perforations of relapsing varicose veins

+∞

323.0

448

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

84.7

323.0

1554

144

PHT99

NOMESCO Finland

Injection of therapeutic or sclerosing agent into other vein

182.9

323.0

506

PHM77

NOMESCO Finland

Endovenous obliteration of v.saphena parva

2887.6

323.0

770

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

70.9

323.0

2155

243

N02BE01

ATC

paracetamol; systemic, rectal

1.7

323.0

25518

165518

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

323.0

12123

64192

B01AB05

ATC

enoxaparin; parenteral

2.9

323.0

11052

36145

B01AF01

ATC

rivaroxaban; oral

2.5

323.0

3186

10151

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

7.2

323.0

6468

8081

PHL76

NOMESCO Finland

Ultrasound guided foam sclerotherapy of long saphenous vein

2839.3

323.0

383

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

54.5

323.0

9450

1809

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

156.1

323.0

1323

PHD78

NOMESCO Finland

Resection of communicating veins of lower leg and thigh

1576.1

323.0

431

PHD76

NOMESCO Finland

Resection of long saphenous vein

10165.0

323.0

4698

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

9.5

323.0

2163

1813

PHL99

NOMESCO Finland

Ultrasound guided foam sclerotherapy of other vein

514.2

306.8

341

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

54.1

297.4

393

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.8

294.8

2168

6058

I80

ICD-10 Finland

Phlebitis and thrombophlebitis

12.9

290.3

568

334

45610

ICD-8 Finland

Varicose veins of other sites, Of scrotum

+∞

290.1

312

S97

ICPC

Chronic ulcer skin

3.2

289.8

1743

4255

N02AX02

ATC

tramadol; systemic, rectal

1.6

287.3

12227

67254

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

791.7

286.3

315

I81

ICD-10 Finland

Portal vein thrombosis

472.9

281.8

314

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

34.7

275.3

395

ZXA05

NOMESCO Finland

Left side

1.7

269.6

6648

31409

PHB78

NOMESCO Finland

Ligature of perforating veins of lower extremity

+∞

266.8

287

B01AB04

ATC

dalteparin; parenteral

3.2

264.5

1562

3757

A02BC02

ATC

pantoprazole; systemic

1.5

259.2

18028

110019

J01DB01

ATC

cefalexin; oral

1.6

256.8

24626

161467

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

251.6

3672

14417

ZXA00

NOMESCO Finland

Right side

1.7

249.5

6971

34044

WX002

NOMESCO Finland

Sedation and analgesia

1.8

249.0

5149

22935

S18

ICPC

Laceration/cut

1.5

239.6

11006

60872

L17

ICPC

Foot/toe symptom/complaint

1.7

239.3

6179

29442

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

233.9

7494

37882

I88.0

ICD-10 Finland

Nonspecific mesenteric lymphadenitis

644.5

232.6

257

B01AB10

ATC

tinzaparin; parenteral

2.6

232.2

1954

5890

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

231.5

3806

15607

ZXA10

NOMESCO Finland

Bilateral

1.8

229.8

4671

20629

4564A

ICD-9 Finland

Varicose veins of other sites, Scrotal varices

+∞

224.9

242

B01AF02

ATC

apixaban; oral

2.3

223.6

2370

8057

PHB76

NOMESCO Finland

Ligature of long saphenous vein

+∞

223.1

240

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.5

220.1

1139

2470

I87.0

ICD-10 Finland

Postthrombotic syndrome

+∞

211.0

227

L14

ICPC

Leg/thigh symptom/complaint

2.4

201.3

1859

5883

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

47.1

199.2

269

N02AA05

ATC

oxycodone; systemic

1.9

199.2

3670

15615

PHD79

NOMESCO Finland

1555.0

196.6

214

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

195.4

2091

7126

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

195.4

1492

4239

J01FF01

ATC

clindamycin; systemic

1.5

189.1

7498

39589

R06.0

ICD-10 Finland

Dyspnoea

1.6

185.1

6100

30763

C03DA01

ATC

spironolactone; oral

2.0

184.6

2749

10797

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

5.5

184.5

601

823

D68.8

ICD-10 Finland

Other specified coagulation defects

7.2

183.6

491

515

E0000UV

ATC

1.5

179.5

10178

57926

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.7

174.6

4337

20218

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

170.6

12720

76062

UJF32

NOMESCO Finland

Coloscopy

1.6

170.1

6253

32298

J01MA02

ATC

ciprofloxacin; systemic

1.4

168.4

10651

61722

I82.80

ICD-10 Finland

Emboli and thrombosis in the subclavian vein

+∞

167.2

180

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

6.3

166.6

488

583

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

164.6

2833

11717

J01MA12

ATC

levofloxacin; systemic

1.6

162.4

5026

24835

J01DA01

ATC

[U] cefalexin; systemic

1.4

161.8

18155

116174

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

4.7

159.0

594

951

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

158.5

5900

30491

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

157.4

5521

28125

I88.9

ICD-10 Finland

Nonspecific lymphadenitis, unspecified

12.1

155.7

312

194

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

155.7

3620

16503

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

154.8

3887

18121

H02AB06

ATC

prednisolone; systemic

1.4

154.7

12521

75536

7504

FHL

Play the depot

98.8

150.7

184

A08

ICPC

Swelling

2.9

147.2

974

2520

K07

ICPC

Swollen ankles/oedema

3.0

147.0

960

2464

WX320

NOMESCO Finland

Spinalanesthesy

1.5

145.9

5560

28815

N03AX16

ATC

pregabalin; oral

1.5

145.2

5712

29815

5613

FHL

Conjunctival occlusion

209.9

144.9

167

PH5GT

NOMESCO Finland

Endovascular embolisation of spermatic vein with radiological guidance

209.9

144.9

167

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

144.5

2538

10548

4538X

ICD-9 Finland

Other venous embolism and thrombosis, Of other specified veins

+∞

144.0

155

R60.9

ICD-10 Finland

Oedema, unspecified

2.6

143.3

1182

3503

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

143.2

5474

28378

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

143.1

9114

52474

L28

ICPC

Limited function/disability (L)

1.7

138.3

3288

15049

D07AC01

ATC

betamethasone; topical

1.4

136.6

8840

50946

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

135.6

3167

14416

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

4.0

134.2

593

1120

PHB99

NOMESCO Finland

Ligature of other vein

109.9

133.3

161

A28

ICPC

Limited function/disability NOS

1.7

132.6

3043

13772

J01AA02

ATC

doxycycline; systemic

1.4

131.7

22214

149119

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

130.3

6251

33948

I86.8

ICD-10 Finland

Varicose veins of other specified sites

60.1

129.6

168

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

128.8

4214

20990

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

128.5

3977

19538

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.8

127.7

2484

10670

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

125.8

6944

38736

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

125.0

9829

58381

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

123.9

7024

39360

SPAT1229

SPAT

Assessment of need for aid

2.0

123.7

1695

6402

WX110

NOMESCO Finland

Local anesthesy

1.3

123.0

19296

127291

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

120.4

5162

27319

45309

ICD-8 Finland

Other venous embolism and thrombosis, NUD (cerebri, cordis, mesenterii, pulmonis exceptis)

+∞

119.8

129

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

118.7

3144

14797

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

117.2

2325

10035

AA1AD

NOMESCO Finland

CT of head and brain

1.5

117.1

5583

30186

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

116.1

2945

13692

A06AD11

ATC

lactulose; oral

1.6

116.0

3350

16130

C07AB07

ATC

bisoprolol; oral

1.3

115.7

11375

69773

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

115.7

2006

8274

SPAT1263

SPAT

Sampling

1.3

115.6

10754

65407

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

115.6

2723

12393

28930

ICD-8 Finland

Other disease of blood and blood-forming organs, Lymphadenitis, unspecified, except mesenteric

+∞

115.2

124

JN4BD

NOMESCO Finland

Extensive body CT

1.7

112.5

2610

11820

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.6

111.7

563

1192

R50.9

ICD-10 Finland

Fever, unspecified

1.6

111.0

3635

18055

I86.2

ICD-10 Finland

Pelvic varices

311.3

110.7

125

M04AA01

ATC

allopurinol; systemic

1.6

110.4

3421

16760

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

109.8

6220

34719

G04CA02

ATC

tamsulosin; oral

1.4

108.8

7543

43642

4540A

ICD-9 Finland

Varicose veins of lower extremities, With ulcer

+∞

107.7

116

UKC02

NOMESCO Finland

Cystoscopy

1.5

107.7

4366

22768

45400

ICD-8 Finland

Varicose veins of lower extremities, With ulcer

+∞

106.8

115

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

106.4

2176

9476

R4110

NOMESCO Finland

Physiotherapy

1.4

105.9

6407

36160

K78

ICPC

Atrial fibrillation/flutter

1.9

105.2

1705

6860

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

104.6

2612

12072

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

104.5

4085

21120

I89.1

ICD-10 Finland

Lymphangitis

11.7

103.1

209

134

I80.2

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

+∞

103.1

111

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

102.6

6177

34801

I87.9

ICD-10 Finland

Disorder of vein, unspecified

20.3

102.4

168

M25.5

ICD-10 Finland

Pain in joint

1.4

102.1

6774

38816

SPAT1153

SPAT

Removal of sutures

1.4

101.2

7477

43624

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

100.8

2287

10274

R18

ICD-10 Finland

Ascites

3.7

100.0

479

973

S29

ICPC

Skin symptom/complaint other

1.5

99.2

3596

18260

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

98.6

4171

21912

SPAT1216

SPAT

Assessment of functional ability

1.6

96.8

3071

15099

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

6.5

94.9

271

314

M01AX05

ATC

glucosamine; oral

1.6

94.8

3134

15560

5619

FHL

Other measure in this category

140.0

94.8

112

K99

ICPC

Cardiovascular disease other

2.7

93.4

688

1906

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

92.8

9662

59235

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

92.7

3293

16627

SPAT1254

SPAT

Administration of medicine

1.5

92.5

3190

15996

ZXC10

NOMESCO Finland

Use of laser

2.8

91.9

648

1746

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

91.5

6857

39978

D07AC13

ATC

mometasone; topical

1.3

91.3

7269

42790

L15

ICPC

Knee symptom/complaint

1.5

90.7

4048

21471

A02BC05

ATC

esomeprazole; systemic

1.3

90.4

9785

60259

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

90.0

13419

86228

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

89.9

2321

10803

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

88.0

4093

21883

S76

ICPC

Skin infection other

2.0

87.8

1170

4358

E000001

ATC

1.4

87.7

4953

27482

K93

ICPC

Pulmonary embolism

5.1

87.2

302

446

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

86.8

4781

26398

J01CE08

ATC

benzathine benzylpenicillin; parenteral

4.6

86.7

331

544

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

86.5

2121

9726

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

1.5

86.5

3297

16892

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

86.1

5158

28913

M54.5

ICD-10 Finland

Low back pain

1.3

85.1

8008

48244

N03AX12

ATC

gabapentin; oral

1.5

84.7

3477

18102

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.7

84.2

1910

8563

R31

ICD-10 Finland

Unspecified haematuria

1.6

83.9

2686

13211

I89.9

ICD-10 Finland

Noninfective disorder of lymphatic vessels and lymph nodes, unspecified

108.1

83.7

101

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

83.7

7226

42965

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

83.2

4895

27332

SPAT1255

SPAT

Intravenous administration of medicine

1.8

83.1

1600

6816

K92.1

ICD-10 Finland

Melaena

1.9

82.1

1258

4948

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

81.3

1803

8027

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.8

81.1

1670

7267

I87.1

ICD-10 Finland

Compression of vein

339.8

81.0

I50.0

ICD-10 Finland

Congestive heart failure

1.8

80.5

1617

6983

SPAT1211

SPAT

Application of soft bandage

1.7

80.3

1924

8761

PHG77

NOMESCO Finland

Intraluminal laser vein occlusion of short saphenous vein

+∞

79.9

P01AB01

ATC

metronidazole; oral, rectal

1.3

79.6

9460

58746

XKD00

NOMESCO Finland

Uroflowmetry

1.4

79.2

4767

26695

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

78.3

3011

15440

ZX120

NOMESCO Finland

Intravenous

1.6

78.1

2184

10371

KFD50

NOMESCO Finland

Resection or ligature of internal spermatic vein

100.6

77.4

K06

ICPC

Prominent veins

17.5

77.4

133

PH2AE

SPAT

3.5

77.4

395

847

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

77.4

3791

20432

R53

ICD-10 Finland

Malaise and fatigue

1.4

77.1

4699

26360

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

77.0

7987

48649

SPAT1301

SPAT

No procedures

1.3

76.9

7273

43724

J01CA04

ATC

amoxicillin; systemic

1.3

76.5

22741

157336

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

76.3

1715

7660

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

76.2

9861

61823

45100

ICD-8 Finland

Phlebitis and thrombophlebitis, Of lower extremities

6.2

74.3

219

266

I87.8

ICD-10 Finland

Other specified disorders of veins

31.1

74.1

108

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

73.9

4461

24969

M10.9

ICD-10 Finland

Gout, unspecified

1.7

73.8

1654

7382

S21

ICPC

Skin texture symptom/complaint

1.5

73.5

2550

12765

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

73.0

5026

28749

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

73.0

9826

61827

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

73.0

684

2168

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

72.9

13425

87671

M02AA07

ATC

piroxicam; topical

1.3

72.1

8175

50299

A02BC03

ATC

lansoprazole; oral

1.3

71.7

6704

40169

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

71.5

1742

7962

D09AB01

ATC

zinc bandage without supplements; topical

2.8

70.9

499

1344

PHM78

NOMESCO Finland

Endovenous obliteration of perforating veins of lower extremity

583.5

70.6

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

70.1

4466

25201

R52.9

ICD-10 Finland

Pain, unspecified

1.6

69.9

1783

8254

ZXC20

NOMESCO Finland

Use of chemical agents

2.9

69.8

476

1256

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.3

69.5

722

2409

L13

ICPC

Hip symptom/complaint

1.5

69.3

2613

13319

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

69.2

4024

22347

M01AX17

ATC

nimesulide; oral

1.3

68.8

5196

30132

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

68.6

1597

7206

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

68.1

9479

59755

K29

ICPC

Cardiovascular sympt/complt other

2.1

67.8

865

3163

I86.4

ICD-10 Finland

Gastric varices

561.0

67.8

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.6

67.5

1759

8188

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

67.4

2596

13292

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

67.3

1359

5872

207

Kela drug reimbursment

Chronic arrhythmias

1.5

67.1

2884

15114

PH5AC

NOMESCO Finland

Flebography of spermatic vein

553.5

66.9

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

66.3

5266

30756

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

66.1

2890

15191

JN4AD

NOMESCO Finland

Body CT examination

1.7

66.0

1672

7722

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

65.6

1540

6961

D07AB08

ATC

desonide; topical

1.5

65.5

2408

12200

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

65.4

1669

7724

E66.8

ICD-10 Finland

Other obesity

1.8

65.3

1285

5504

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.2

65.1

376

887

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

64.7

6559

39653

O22.0

ICD-10 Finland

Varicose veins of lower extremity in pregnancy

15.3

64.4

116

K28

ICPC

Limited function/disability (K)

2.7

64.1

475

1322

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

63.9

1410

6256

K92.0

ICD-10 Finland

Haematemesis

2.3

63.5

658

2193

N05CF01

ATC

zopiclone; oral

1.3

63.5

7326

45036

TQW80

NOMESCO Finland

Local dermatologic skincare

2.3

63.4

631

2062

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

63.3

1057

4287

A02BC01

ATC

omeprazole; systemic

1.3

63.1

6309

38048

L16

ICPC

Ankle symptom/complaint

1.6

62.9

1973

9627

SPAT1325

SPAT

Vaccination

1.3

62.9

7408

45646

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

62.6

2592

13471

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

62.5

1224

5235

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

62.1

3770

21059

SPAT1260

SPAT

Consultation of another employee

1.4

61.9

3775

21107

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

61.7

1857

8969

I82

ICD-10 Finland

Other venous embolism and thrombosis

12.2

61.7

122

R04.0

ICD-10 Finland

Epistaxis

1.7

61.7

1542

7093

I82.21

ICD-10 Finland

Emboli and thrombosis in the inferior vena cava

260.6

61.7

R03AC02

ATC

salbutamol; inhalant

1.2

61.7

13254

87439

M01AH05

ATC

etoricoxib; oral

1.2

61.4

15216

101854

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

61.3

3685

20548

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

61.2

2659

13952

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.3

61.2

613

2010

I26

ICD-10 Finland

Pulmonary embolism

4.3

60.7

246

431

ZXC08

NOMESCO Finland

Other ablative laser

+∞

60.3

WZC30

NOMESCO Finland

Teaching

1.4

60.1

2970

15978

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

59.6

886

3444

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.2

59.4

642

2182

PHB77

NOMESCO Finland

Ligature of short saphenous vein

+∞

59.4

127

Kela drug reimbursment

Transplant complication

2.7

59.1

434

1202

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.5

59.1

2014

10021

G47.3

ICD-10 Finland

Sleep apnoea

1.3

59.0

5537

33060

WX892

NOMESCO Finland

Monitored bed care

1.6

58.9

1731

8311

L04AA06

ATC

mycophenolic acid; systemic

2.6

58.7

465

1346

M01AB05

ATC

diclofenac; systemic, rectal

1.2

58.6

18172

124142

R02

ICPC

Shortness of breath/dyspnoea

1.5

58.5

2386

12350

Z51.5

ICD-10 Finland

Palliative care

1.8

58.5

1196

5187

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

58.4

821

3124

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

58.3

4047

23098

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

58.0

2693

14310

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

57.9

956

3862

J01FA06

ATC

roxithromycin; oral

1.2

57.8

9911

63688

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

57.8

2232

11415

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

57.5

7882

49370

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.8

56.7

403

1093

PHK76

NOMESCO Finland

Endovenous radiotherapy of long saphenous vein

+∞

56.6

M48.0

ICD-10 Finland

Spinal stenosis

1.5

56.5

2201

11280

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

56.4

2028

10209

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

56.0

1175

5135

PHL77

NOMESCO Finland

Ultrasound guided foam sclerotherapy of short saphenous vein

+∞

55.7

J01CF05

ATC

flucloxacillin; systemic

1.9

55.7

888

3543

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.0

55.6

803

3087

R42

ICD-10 Finland

Dizziness and giddiness

1.3

55.5

4324

25106

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

55.5

14439

96716

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

55.1

12514

82686

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

55.0

1841

9119

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.1

54.3

660

2367

M01AC06

ATC

meloxicam; systemic, rectal

1.2

54.2

8051

50832

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

54.1

10175

65911

H02AB02

ATC

dexamethasone; systemic

1.5

54.0

1989

10065

I50

ICD-10 Finland

Heart failure

2.2

54.0

574

1938

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

53.8

893

3612

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.9

53.5

912

3725

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.4

53.1

282

626

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

53.1

2382

12560

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.1

53.1

632

2244

I82.0

ICD-10 Finland

Budd-Chiari syndrome

440.7

53.0

Z94.4

ICD-10 Finland

Liver transplant status

7.2

53.0

139

144

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

53.0

4983

29706

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.7

52.7

1189

5310

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

52.6

1377

6410

SPAT1053

SPAT

Memory test

1.4

52.6

2532

13539

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

52.5

1404

6571

O22.3

ICD-10 Finland

Deep phlebothrombosis in pregnancy

12.5

52.4

102

ZZA00

NOMESCO Finland

Split skin graft

2.1

52.4

663

2417

GAE40

NOMESCO Finland

Operation on rib and soft tissues for thoracic outlet syndrome

10.6

52.2

110

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

51.4

1476

7039

Z71.8

ICD-10 Finland

Other specified counselling

1.3

51.4

5385

32549

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

51.4

4722

28046

H02AB04

ATC

methylprednisolone; systemic

1.4

51.4

3110

17326

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

51.4

2487

13309

L90

ICPC

Osteoarthrosis of knee

1.8

51.4

906

3744

G04CA01

ATC

alfuzosin; oral

1.4

51.3

3534

20108

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

3.4

51.1

272

606

28910

ICD-8 Finland

Other disease of blood and blood-forming organs, Chronic lymphadenitis

+∞

51.1

Z00.0

ICD-10 Finland

General medical examination

1.3

51.0

4030

23423

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

50.8

3047

16951

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

50.7

1967

10062

D01BA02

ATC

terbinafine; oral; topical

1.3

50.7

6082

37396

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

50.6

2322

12299

WW500

NOMESCO Finland

Blood transfusion

1.9

50.6

858

3499

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.3

50.5

485

1557

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

49.8

3797

21939

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.1

49.6

586

2076

J02AC01

ATC

fluconazole; systemic

1.2

49.5

8650

55474

R55

ICD-10 Finland

Syncope and collapse

1.4

49.4

2245

11864

SPAT1310

SPAT

Counselling related to known health issue

1.2

49.4

7048

44208

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

49.3

3309

18746

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.4

49.1

3149

17709

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

49.1

1720

8605

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

48.9

2853

15789

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.4

48.8

458

1456

H02AB07

ATC

prednisone; oral

1.4

48.8

3084

17300

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.2

48.8

6792

42474

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

48.7

2519

13643

JJC00

NOMESCO Finland

Allogenic transplantation of liver

9.8

48.5

106

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

48.2

5253

31886

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1.8

48.1

872

3636

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

47.9

5264

31982

E66.00

ICD-10 Finland

Metabolic syndrome

1.6

47.5

1208

5581

B01AX05

ATC

fondaparinux; parenteral

4.1

47.4

198

359

L03

ICPC

Low back symptom/complaint

1.3

47.1

4889

29479

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

47.1

1535

7549

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

47.0

3490

20075

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

47.0

1619

8066

E000006

ATC

1.6

46.9

1302

6154

I82.1

ICD-10 Finland

Thrombophlebitis migrans

137.2

46.7

G04BD12

ATC

mirabegron; oral

1.5

46.7

1721

8704

SPAT1262

SPAT

Handing over of treatment supplies

1.3

46.5

4085

24081

M01AH02

ATC

rofecoxib; oral

1.4

46.4

2398

12979

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.2

46.4

486

1631

M03BX02

ATC

tizanidine; oral

1.2

46.3

16390

112141

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.7

46.2

344

963

A02BA02

ATC

ranitidine; systemic

1.3

45.9

4193

24849

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

45.7

5589

34382

PG9AC

NOMESCO Finland

Arteriography with X-ray not elsewhere classified

4.9

45.7

163

252

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

45.6

1399

6780

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

45.5

19254

133714

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.3

45.1

3534

20483

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

44.9

15130

102958

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

44.7

962

4235

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

44.7

929

4047

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.0

44.4

607

2284

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.5

44.2

368

1098

TK800

NOMESCO Finland

Hemodialysis

2.1

44.1

546

1973

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

44.0

693

2753

K02.1

ICD-10 Finland

Caries of dentine

1.2

44.0

15040

102398

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

43.9

1259

5998

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

43.9

13461

90784

XX3DW

NOMESCO Finland

Time consuming IT work

1.4

43.8

2084

11104

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

43.8

18852

130875

L57.0

ICD-10 Finland

Actinic keratosis

1.5

43.8

1550

7769

S06

ICPC

Rash localized

1.7

43.6

980

4370

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.6

43.5

1313

6336

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

43.4

4673

28275

A29

ICPC

General symptom/complaint other

1.4

43.3

2142

11496

J01MA14

ATC

moxifloxacin; systemic

1.4

43.2

1981

10476

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.7

43.2

1047

4772

ZXC35

NOMESCO Finland

Use of radio waves

8.6

43.1

101

XF404

NOMESCO Finland

Ambulatory ECG

1.4

43.0

1895

9947

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

42.9

10583

69950

P20

ICPC

Memory disturbance

1.5

42.9

1890

9918

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.6

42.9

1125

5240

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

42.7

6295

39521

PH6GT

NOMESCO Finland

Endovascular embolisation of ovarian vein with radiological guidance

+∞

42.7

R51.80

ICD-10 Finland

Headache

1.3

42.6

3106

17798

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

42.6

2068

11058

A04AA01

ATC

ondansetron; systemic, rectal

1.6

42.5

1205

5723

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

42.5

5834

36339

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

42.4

1665

8531

M01AE02

ATC

naproxen; oral, rectal

1.2

42.2

14422

98036

O22.2

ICD-10 Finland

Superficial thrombophlebitis in pregnancy

16.6

42.1

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.6

42.0

1238

5942

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

41.6

2166

11731

A01

ICPC

Pain general/multiple sites

1.5

41.5

1354

6657

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

41.5

1096

5111

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.0

41.5

601

2316

A41.8

ICD-10 Finland

Other specified sepsis

2.4

41.4

377

1180

N06AX11

ATC

mirtazapine; oral

1.2

41.4

7125

45454

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

41.3

9052

59129

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.1

41.1

525

1923

C08CA01

ATC

amlodipine; oral

1.2

41.0

7399

47414

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.2

41.0

6761

42933

D01AC02

ATC

miconazole; topical

1.4

40.7

1801

9458

L04AD01

ATC

ciclosporin; systemic

2.2

40.7

439

1495

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.1

40.7

518

1897

R05FB02

ATC

cough suppressants and expectorants

1.2

40.6

8532

55493

C09AA05

ATC

ramipril; oral

1.2

40.5

5314

32899

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

40.5

1608

8259

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.1

40.5

469

1650

S19

ICPC

Skin injury other

1.8

40.4

769

3259

A07AA11

ATC

rifaximin; oral

8.7

40.4

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.5

40.3

1352

6690

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

40.3

1687

8762

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

40.2

615

2418

L08

ICPC

Shoulder symptom/complaint

1.3

40.1

3755

22289

R06AE07

ATC

cetirizine; oral

1.2

40.1

10093

66724

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

39.9

1778

9347

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.0

39.6

540

2034

J01EA01

ATC

trimethoprim; systemic

1.3

39.5

4514

27487

J01FA09

ATC

clarithromycin; systemic

1.2

39.5

7345

47184

X58

ICD-10 Finland

Exposure to other specified factors

1.3

39.3

3174

18456

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

39.2

598

2349

R35

ICD-10 Finland

Polyuria

1.5

39.0

1396

7008

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

38.9

1969

10608

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

38.9

910

4107

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

38.9

1662

8668

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

38.9

2274

12568

R05

ICD-10 Finland

Cough

1.3

38.9

3781

22554

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

38.6

6991

44768

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

38.4

2536

14298

PH2BC

NOMESCO Finland

Extensive flebography of lower extremity with X-ray

61.2

38.3

ZXC30

NOMESCO Finland

Use of microwaves

9.7

38.3

C07AA05

ATC

propranolol; systemic

1.3

38.3

4090

24689

SPAT1172

SPAT

Guidance concerning hydration

2.3

38.3

373

1210

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.4

38.2

359

1142

T90

ICPC

Diabetes non-insulin dependent

1.2

38.1

4869

30028

R33

ICD-10 Finland

Retention of urine

1.4

38.1

1960

10589

2892A

ICD-9 Finland

Other diseases of blood and blood-forming organs, Nonspecific mesenteric lymphadenitis

+∞

38.1

205

Kela drug reimbursment

Chronic hypertension

1.2

38.1

5848

36816

S01

ICPC

Pain/tenderness of skin

1.7

38.0

774

3353

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

3.2

38.0

213

495

J01FA10

ATC

azithromycin; systemic

1.2

37.7

14500

99154

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.4

37.6

336

1044

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

37.5

10760

71831

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

2.0

37.5

534

2045

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

37.5

2001

10885

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

1.8

37.3

689

2893

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

37.2

2984

17322

M09AX01

ATC

hyaluronic acid; parenteral

1.7

37.0

748

3233

NHQ40

NOMESCO Finland

Amputation of toe

2.2

36.7

391

1323

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

36.7

1186

5819

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.7

36.4

827

3703

L29

ICPC

Musculoskeletal sympt/complt other

1.5

36.3

1307

6571

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.8

36.3

703

2999

A04AA02

ATC

granisetron; systemic, transdermal

1.6

36.0

1076

5181

R07.3

ICD-10 Finland

Other chest pain

1.4

35.9

1786

9586

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

35.7

3154

18558

SPAT1312

SPAT

General health counselling

1.2

35.7

6969

44899

K70.4

ICD-10 Finland

Alcoholic hepatic failure

4.3

35.6

143

251

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

35.6

5592

35249

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.0

35.3

460

1702

D07AD01

ATC

clobetasol; topical

1.3

35.2

3051

17900

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.6

35.1

964

4543

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.3

35.1

349

1143

XW000

NOMESCO Finland

Bone marrow biopsy

1.7

35.1

804

3609

R03BB04

ATC

tiotropium bromide; inhalant

1.4

35.1

2150

11971

M79.1

ICD-10 Finland

Myalgia

1.3

34.9

2566

14702

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.8

34.8

593

2424

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

34.8

927

4334

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

2.8

34.6

234

620

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.1

34.5

440

1612

XF402

NOMESCO Finland

ECG with work load test

1.4

34.5

2164

12093

Z01.2

ICD-10 Finland

Dental examination

1.2

34.4

9615

63916

R52.0

ICD-10 Finland

Acute pain

1.8

34.4

641

2700

J01MA01

ATC

ofloxacin; systemic

1.4

34.4

1896

10368

E66.9

ICD-10 Finland

Obesity, unspecified

1.7

34.4

700

3034

SPAT1097

SPAT

Recording of ECG

1.3

34.3

2815

16390

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

34.2

996

4762

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

34.2

1802

9772

A04

ICPC

Weakness/tiredness general

1.3

34.2

2389

13582

C07AB02

ATC

metoprolol; systemic

1.3

34.0

4180

25633

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.6

34.0

973

4635

M02AA10

ATC

ketoprofen; topical

1.3

33.9

3060

18045

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

33.9

3389

20260

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

33.8

1909

10478

L84

ICD-10 Finland

Corns and callosities

1.8

33.8

626

2631

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

33.7

4648

28873

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

33.6

1057

5154

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

33.6

4688

29158

W19

ICD-10 Finland

Unspecified fall

1.4

33.5

1871

10249

L30.3

ICD-10 Finland

Infective dermatitis

1.7

33.5

721

3176

130

Kela drug reimbursment

Malignant tumour

1.4

33.5

1752

9490

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

33.3

3191

18972

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.9

33.2

547

2211

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.7

33.2

713

3140

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.4

32.9

1495

7885

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.7

32.9

698

3063

A11CC03

ATC

alfacalcidol; systemic

1.9

32.8

491

1918

PH2ST

NOMESCO Finland

Endovascular thrombolysis of pelvic and lower leg veins with radiological guidance

275.4

32.8

R5110

SPAT

2.0

32.7

423

1562

H25.8

ICD-10 Finland

Other senile cataract

1.4

32.5

1572

8389

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

32.5

1913

10578

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.6

32.4

940

4494

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

10.4

32.3

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

32.3

1396

7292

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

32.3

2076

11647

C08CA13

ATC

lercanidipine; oral

1.3

32.0

2211

12543

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

32.0

624

2668

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.1

31.9

371

1308

A99

ICPC

Disease/condition unspecnature/site

1.4

31.9

1439

7582

JN4CD

NOMESCO Finland

Very extensive body CT

1.7

31.9

760

3449

M10.0

ICD-10 Finland

Idiopathic gout

1.7

31.8

718

3207

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.9

31.8

468

1816

A10BA02

ATC

metformin; oral

1.2

31.8

6155

39551

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.6

31.7

255

749

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.3

31.7

2557

14842

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.7

31.7

758

3443

N30.0

ICD-10 Finland

Acute cystitis

1.4

31.6

2067

11624

PH7YT

NOMESCO Finland

Dilatation of inferior vena cava or lower extremity vein with stent

138.4

31.6

I82.20

ICD-10 Finland

Emboli and thrombosis of the superior vena cava

138.4

31.6

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

31.6

494

1961

4151A

ICD-9 Finland

Acute pulmonary heart disease, Pulmonary embolism and infarction

4.8

31.6

113

177

R5140

NOMESCO Finland

Monitoring the use of the aid

1.3

31.4

2367

13601

N19

ICD-10 Finland

Unspecified kidney failure

1.7

31.4

642

2785

PH9AT

NOMESCO Finland

Expansion (PTA) of vein not elsewhere classified

94.8

31.4

C05AA08

ATC

fluocortolone; rectal, topical

1.3

31.3

3028

18014

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.6

31.2

769

3523

N05BA04

ATC

oxazepam; oral

1.2

31.1

5240

33214

N06AA09

ATC

amitriptyline; systemic

1.4

31.0

1690

9217

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.5

31.0

1177

5986

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.2

31.0

6227

40142

S22.3

ICD-10 Finland

Fracture of rib

1.4

31.0

1416

7478

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.5

31.0

1281

6631

H26.4

ICD-10 Finland

After-cataract

1.5

30.9

1180

6009

C09AA02

ATC

enalapril; systemic

1.2

30.9

4095

25305

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.8

30.9

545

2256

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

1.8

30.8

552

2296

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

30.8

3442

20850

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.5

30.8

1012

4984

H81

ICPC

Excessive ear wax

1.3

30.8

3103

18560

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

30.7

1258

6499

PH2AC

NOMESCO Finland

Flebography of lower extremity with X-ray

15.5

30.6

4560A

ICD-9 Finland

Varicose veins of other sites, Oesophageal varices with bleeding

+∞

30.6

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.1

30.6

184

450

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

8.4

30.6

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

2.7

30.5

227

638

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.3

30.5

2508

14593

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

30.5

1062

5304

C10AA01

ATC

simvastatin; oral

1.2

30.4

8869

59029

R05

ICPC

Cough

1.2

30.3

4372

27267

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

3.8

30.2

138

274

D02AE01

ATC

carbamide; topical

1.4

30.2

1335

7004

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.4

30.2

1587

8602

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

30.2

9208

61494

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

30.1

1107

5594

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

1.7

30.0

689

3096

C03AA03

ATC

hydrochlorothiazide; oral

1.4

29.9

1541

8323

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.3

29.9

2671

15723

I88.8

ICD-10 Finland

Other nonspecific lymphadenitis

7.4

29.8

JCA32

NOMESCO Finland

Endoscopic injection in oesophagus

9.1

29.8

XJH00

NOMESCO Finland

Transanal ultrasonography

1.4

29.8

1653

9042

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.2

29.7

4554

28575

R01AD09

ATC

mometasone; nasal

1.2

29.7

10838

73352

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.8

29.7

546

2293

M05BA04

ATC

alendronic acid; oral

1.6

29.5

769

3578

S22

ICPC

Nail symptom/complaint

1.5

29.5

1024

5109

UJD02

NOMESCO Finland

Gastroscopy

1.6

29.5

912

4429

SAA02

NOMESCO Finland

Basic examination of mouth

1.1

29.4

16521

115260

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.4

29.4

1684

9264

WX882

NOMESCO Finland

High dependency care

1.8

29.4

549

2318

AN1

Coronary angiography

1.3

29.3

2403

13973

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.1

29.2

331

1157

C01AA05

ATC

digoxin; systemic

1.4

29.2

1578

8596

D68.9

ICD-10 Finland

Coagulation defect, unspecified

4.5

29.2

111

186

B02AA02

ATC

tranexamic acid; systemic

1.3

29.1

2853

16993

G04BD08

ATC

solifenacin; oral

1.5

29.1

1045

5254

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

29.0

1367

7261

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.3

29.0

2208

12703

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.2

29.0

4953

31410

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

29.0

1687

9308

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

3.9

28.9

127

244

S70.0

ICD-10 Finland

Contusion of hip

1.7

28.9

608

2664

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

28.9

1528

8289

N05BA01

ATC

diazepam; systemic, rectal

1.3

28.9

2651

15657

XX5WT

NOMESCO Finland

Laser therapy with ultrasound guidance

+∞

28.8

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.6

28.7

713

3274

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.5

28.6

1062

5376

D68.2

ICD-10 Finland

Hereditary deficiency of other clotting factors

5.3

28.4

129

TQW99

NOMESCO Finland

Other minor procedure on skin

1.6

28.4

870

4215

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.4

28.4

1403

7519

M01AB01

ATC

indometacin; systemic, rectal

1.4

28.3

1719

9549

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.5

28.3

935

4610

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.2

28.3

315

1093

PH1ST

NOMESCO Finland

Endovascular thrombolysis of upper extremity veins with radiological guidance

237.8

28.2

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.7

28.1

573

2486

N04BC05

ATC

pramipexole; oral

1.5

28.1

1191

6195

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.3

28.0

270

876

L12

ICPC

Hand/finger symptom/complaint

1.3

28.0

2654

15737

JCA20

NOMESCO Finland

Ligature of oesophageal varices

123.4

28.0

J20

ICD-10 Finland

Acute bronchitis

1.4

27.9

1772

9912

L30.0

ICD-10 Finland

Nummular dermatitis

1.7

27.9

679

3099

D01AE15

ATC

terbinafine; topical

1.4

27.9

1474

7999

PHL79

NOMESCO Finland

Ultrasound guided foam sclerotherapy of anterior saphenous vein

+∞

27.8

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.2

27.8

4178

26141

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

27.8

25982

187571

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

27.8

2534

14952

M01AC01

ATC

piroxicam; systemic, rectal

1.3

27.7

2643

15681

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

27.7

3923

24398

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.2

27.6

292

990

WX402

NOMESCO Finland

General anaesthesia

1.2

27.5

3589

22115

Z86.7

ICD-10 Finland

Personal history of diseases of the circulatory system

11.4

27.5

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

1.8

27.5

473

1942

S08

ICPC

Skin colour change

1.6

27.5

787

3752

E87.5

ICD-10 Finland

Hyperkalaemia

2.1

27.5

318

1121

D01AC03

ATC

econazole; topical

1.4

27.5

1273

6742

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

27.4

2111

12164

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.8

27.4

464

1896

H03AA01

ATC

levothyroxine sodium; systemic

1.2

27.4

3881

24137

0350X

ICD-9 Finland

Erysipelas[ERYSIPELAS ALIA DEFINITA SEU NUD]

2.7

27.3

193

527

Z30.2

ICD-10 Finland

Sterilization

1.3

27.3

2390

14021

G03AC03

ATC

levonorgestrel; systemic

1.3

27.3

1817

10242

V03AE01

ATC

polystyrene sulfonate; oral

2.2

27.2

285

961

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.2

27.2

3713

22994

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.4

27.2

1330

7114

J02AC02

ATC

itraconazole; systemic

1.2

27.2

3735

23147

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

27.1

1789

10069

A12AA04

ATC

calcium carbonate; oral

2.0

27.1

343

1258

I85

ICD-10 Finland

Oesophageal varices

+∞

26.9

O87.0

ICD-10 Finland

Superficial thrombophlebitis in the puerperium

29.2

26.8

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.6

26.8

804

3877

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.1

26.8

316

1125

S80.0

ICD-10 Finland

Contusion of knee

1.4

26.8

1175

6158

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

26.8

5981

38853

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.3

26.7

252

809

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.4

26.6

1589

8799

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

26.6

2001

11488

LGA21

NOMESCO Finland

Laparoscopic sterilisation by constriction of Fallopian tubes

1.5

26.6

987

4994

XG466

NOMESCO Finland

Sleep oxymetry

1.6

26.6

700

3267

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

1.4

26.6

1137

5926

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.8

26.5

521

2237

TFP20

NOMESCO Finland

Cardiodefibrillation

1.4

26.5

1462

7991

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

26.5

2070

11952

-50

ICPC

Medication/prescr/renewal

1.6

26.5

789

3799

M10

ICD-10 Finland

Gout

1.5

26.4

925

4624

WZA90

NOMESCO Finland

Other doctors statement

1.2

26.4

4835

30847

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

26.3

573

2535

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

26.3

1542

8512

L28.0

ICD-10 Finland

Lichen simplex chronicus

2.6

26.3

209

613

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

26.2

1333

7181

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.5

26.2

1017

5197

PH7FT

NOMESCO Finland

Inmplantation of filter to inferior vena cava with radiological guidance

18.9

26.2

L04AX01

ATC

azathioprine; systemic

1.5

26.1

872

4311

D07XC01

ATC

betamethasone, combinations; topical

1.3

26.1

2599

15504

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

26.1

2599

15505

R04.2

ICD-10 Finland

Haemoptysis

1.6

26.1

696

3260

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.4

26.0

1138

5959

C10AA05

ATC

atorvastatin; oral

1.2

26.0

7892

52547

C07AG02

ATC

carvedilol; oral

1.5

26.0

1084

5621

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.1

25.9

293

1024

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

25.9

2690

16129

C01DA14

ATC

isosorbide mononitrate; oral

1.2

25.9

3081

18779

PH1AT

NOMESCO Finland

Endovascular extension of superior vena cava and of arteries of upper extremity

23.0

25.9

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.1

25.9

320

1162

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.6

25.8

198

568

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

25.8

1527

8447

A10BH05

ATC

linagliptin; oral

1.5

25.8

827

4052

D01AE16

ATC

amorolfine; topical

1.3

25.7

2119

12328

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.3

25.6

2056

11915

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.4

25.6

1479

8145

K83.0

ICD-10 Finland

Cholangitis

2.2

25.6

281

970

K72.1

ICD-10 Finland

Chronic hepatic failure

7.7

25.6

B03XA02

ATC

darbepoetin alfa; parenteral

1.9

25.6

377

1468

SPAT1151

SPAT

Treatment of major wounds

2.3

25.4

251

823

B01AE07

ATC

dabigatran etexilate; oral

1.6

25.4

677

3172

PH9ST

NOMESCO Finland

Intravenous thrombolysis of other vein

42.4

25.3

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.5

25.3

212

641

Z94.0

ICD-10 Finland

Kidney transplant status

2.2

25.3

261

876

JAF10

NOMESCO Finland

Repair of umbilical hernia

1.7

25.1

549

2434

K59.1

ICD-10 Finland

Functional diarrhoea

1.5

25.1

840

4157

M76.6

ICD-10 Finland

Achilles tendinitis

1.5

25.1

898

4514

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.4

25.0

1408

7725

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.5

25.0

982

5034

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.6

24.9

694

3290

E000003

ATC

1.5

24.8

892

4484

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.4

24.8

1091

5721

RD210

NOMESCO Finland

1.9

24.8

363

1411

-1

NOMESCO Finland

1.2

24.8

7845

52365

L60.0

ICD-10 Finland

Ingrowing nail

1.6

24.7

747

3610

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.5

24.7

930

4723

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.7

24.7

547

2434

A10BJ02

ATC

liraglutide; parenteral

1.8

24.6

451

1894

J01CF02

ATC

cloxacillin; systemic

1.7

24.5

504

2197

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

3.0

24.5

147

363

M77.4

ICD-10 Finland

Metatarsalgia

1.5

24.4

913

4632

WX212

NOMESCO Finland

Femoral plexus blockade

2.1

24.4

295

1061

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.5

24.3

771

3771

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.4

24.3

1081

5680

H02

ICPC

Hearing complaint

1.3

24.3

1968

11419

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.5

24.2

950

4868

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

2.8

24.2

162

429

160

Kela drug reimbursment

exenatide

1.9

24.2

393

1585

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.0

24.2

322

1205

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

1.9

24.1

377

1498

KED22

NOMESCO Finland

Transurethral resection of prostate

1.4

24.1

1503

8385

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.6

24.1

609

2814

R52.2

ICD-10 Finland

Other chronic pain

1.6

24.0

580

2647

GD1AD

NOMESCO Finland

Thorax CT examination

1.5

23.8

804

3990

ZXC50

NOMESCO Finland

Cryotherapy

1.7

23.8

474

2044

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.5

23.7

996

5176

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.4

23.6

1192

6412

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.5

23.6

794

3936

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.8

23.6

409

1688

JJ5AT

NOMESCO Finland

8.4

23.5

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.3

23.5

1579

8913

D03BA52

ATC

collagenase, combinations; topical

3.1

23.5

136

328

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

3.1

23.5

139

340

A12BA01

ATC

potassium chloride; oral

1.6

23.4

684

3279

N18.0

ICD-10 Finland

End-stage renal disease

2.1

23.4

268

944

6123

FHL

Radical surgery

1.5

23.4

861

4351

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.5

23.4

739

3611

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.5

23.3

740

3619

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.3

23.3

1637

9300

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.7

23.3

499

2202

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.7

23.2

531

2386

K76.7

ICD-10 Finland

Hepatorenal syndrome

6.0

23.2

R13

ICD-10 Finland

Dysphagia

1.4

23.2

1131

6047

WX722

NOMESCO Finland

PEEP

1.5

23.2

978

5087

R11

ICD-10 Finland

Nausea and vomiting

1.4

23.2

1328

7305

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.6

23.2

674

3229

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.3

23.0

2453

14749

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.2

23.0

3184

19724

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.6

23.0

612

2866

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.4

23.0

205

640

A07AA02

ATC

nystatin; oral

1.5

23.0

958

4970

QDA10

NOMESCO Finland

Incision of skin of lower limb

2.6

22.9

174

498

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.5

22.9

867

4407

I86.3

ICD-10 Finland

Vulval varices

34.2

22.9

C09CA01

ATC

losartan; oral

1.2

22.9

4591

29497

R4120

NOMESCO Finland

Occupational therapy

1.4

22.9

1213

6584

3AC01

NOMESCO Finland

2.3

22.8

226

744

SPAT1167

SPAT

Insertion of urinary catheter

1.6

22.8

605

2830

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.7

22.8

530

2393

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.3

22.8

2214

13161

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

1.8

22.8

409

1708

J45.1

ICD-10 Finland

Nonallergic asthma

1.4

22.7

1206

6549

A05AA02

ATC

ursodeoxycholic acid; oral

2.0

22.7

313

1189

WX213

NOMESCO Finland

Lower leg blockade

2.5

22.7

182

537

R01AD08

ATC

fluticasone; nasal

1.2

22.7

6431

42521

B03BA03

ATC

hydroxocobalamin; parenteral

1.4

22.7

1045

5531

K60

ICPC

Cardiovascular, Result test/procedure

2.8

22.7

154

413

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

3.6

22.6

107

221

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.4

22.6

1243

6792

WX109

NOMESCO Finland

Extensive surface anesthesy of skin with external ointment or geel

10.3

22.6

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.8

22.5

416

1753

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

2.4

22.5

199

620

WX199

NOMESCO Finland

Other local analgesia

1.7

22.4

453

1964

SPAT1234

SPAT

Support of social functional capacity

1.5

22.4

808

4068

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

1.9

22.4

327

1272

HA1AA

NOMESCO Finland

X-ray mammography

1.5

22.3

704

3439

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.6

22.3

664

3198

45199

ICD-8 Finland

Phlebitis and thrombophlebitis, Of other and unspecified sites

+∞

22.3

I95.1

ICD-10 Finland

Orthostatic hypotension

1.6

22.3

559

2578

A01AB09

ATC

miconazole; local oral

1.3

22.2

1420

7952

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

22.2

1370

7628

M15

ICD-10 Finland

Polyarthrosis

1.7

22.2

490

2182

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

22.2

5188

33769

A10AE04

ATC

insulin glargine; parenteral

1.3

22.1

1991

11719

X57

ICD-10 Finland

Unspecified privation

1.7

22.0

445

1929

A10BH01

ATC

sitagliptin; oral

1.3

22.0

1776

10298

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

1.8

22.0

376

1546

H04.10

ICD-10 Finland

Dry eye syndrome

1.3

21.9

1592

9095

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

2.1

21.9

245

856

U04

ICPC

Incontinence urine

1.6

21.8

617

2936

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.2

21.8

242

842

S06.0

ICD-10 Finland

Concussion

1.3

21.7

2006

11844

N05CD07

ATC

temazepam; oral

1.3

21.7

2292

13762

B35.3

ICD-10 Finland

Tinea pedis

1.5

21.7

754

3764

K22

ICPC

Risk factor cardiovascular disease

1.5

21.7

843

4311

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.3

21.7

1433

8069

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.5

21.7

774

3889

M54.2

ICD-10 Finland

Cervicalgia

1.4

21.6

1339

7460

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

1.9

21.6

337

1343

A10BB12

ATC

glimepiride; oral

1.4

21.6

1363

7621

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

2.3

21.5

199

636

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.7

21.5

421

1809

WX872

NOMESCO Finland

Intensive care

1.4

21.5

1046

5593

NG2AA

NOMESCO Finland

Patella X-ray examination

1.8

21.4

381

1587

G04CB02

ATC

dutasteride; oral

1.3

21.4

1615

9273

S04

ICPC

Lump/swelling localized

1.3

21.4

1613

9262

C08CA02

ATC

felodipine; oral

1.3

21.4

1606

9216

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.2

21.4

2526

15375

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.3

21.3

205

665

PH7AC

NOMESCO Finland

Lumbal cavography with X-ray

22.4

21.3

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.4

21.3

916

4785

D07AA02

ATC

hydrocortisone; topical

1.2

21.2

2827

17439

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.7

21.2

497

2253

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.3

21.2

1615

9289

W78

ICPC

Pregnancy

0.8

21.1

1457

13967

K70.1

ICD-10 Finland

Alcoholic hepatitis

2.6

21.1

162

468

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.4

21.1

1036

5550

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.6

21.0

594

2826

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

21.0

5388

35312

SPAT1104

SPAT

Monitoring of emergency patient

1.4

21.0

1228

6780

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.5

20.9

850

4389

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

1.8

20.9

365

1510

N17

ICPC

Vertigo/dizziness

1.3

20.9

1669

9661

R60.1

ICD-10 Finland

Generalized oedema

2.9

20.9

134

346

WX111

NOMESCO Finland

Local infiltration anesthesia

1.7

20.9

412

1772

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

20.9

1623

9360

B04

ICPC

Blood symptom/complaint

3.8

20.8

187

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.2

20.8

2573

15735

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

1.8

20.8

353

1447

-60

ICPC

Result test/procedure

1.4

20.8

1026

5498

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

2.3

20.8

202

660

B01AC04

ATC

clopidogrel; oral

1.2

20.8

3130

19555

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

20.7

6631

44193

A07AA09

ATC

vancomycin; oral

2.2

20.7

224

769

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.4

20.7

177

543

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

1.9

20.7

331

1329

KFD56

NOMESCO Finland

Excision of varicocele

64.8

20.7

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.6

20.7

629

3047

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.3

20.7

1689

9810

R03AC03

ATC

terbutaline; inhalant

1.2

20.7

2739

16880

T82

ICPC

Obesity

1.5

20.7

671

3302

B99

ICD-10 Finland

Other and unspecified infectious diseases

1.8

20.6

379

1598

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

1.5

20.6

650

3177

XCK10

NOMESCO Finland

Photography of fundus of eye

1.3

20.5

1858

10942

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.5

20.5

711

3552

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

9.7

20.5

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

2.1

20.4

241

861

Z02.4

ICD-10 Finland

Examination for driving licence

1.2

20.4

5193

34010

M66.0

ICD-10 Finland

Rupture of popliteal cyst

2.2

20.3

209

702

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

1.6

20.3

617

2988

XG410

NOMESCO Finland

Flow-volume spirometry

1.5

20.3

766

3895

L72.1

ICD-10 Finland

Trichilemmal cyst

1.4

20.3

1176

6484

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.2

20.3

3043

18998

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

2.0

20.3

282

1078

QDB10

SPAT

3.0

20.3

125

314

K76.6

ICD-10 Finland

Portal hypertension

12.2

20.3

Z01.7

ICD-10 Finland

Laboratory examination

1.3

20.2

2089

12511

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.6

20.2

555

2622

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

20.2

4373

28258

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.5

20.2

751

3810

E86

ICD-10 Finland

Volume depletion

1.7

20.1

415

1811

K72.9

ICD-10 Finland

Hepatic failure, unspecified

3.2

20.1

110

256

U05

ICPC

Urination problems other

1.5

20.1

767

3912

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.3

20.0

1354

7650

L03AA13

ATC

pegfilgrastim; parenteral

1.6

20.0

542

2552

8502

FHL

Evacuation and abrasion

1.6

20.0

556

2637

I49.5

ICD-10 Finland

Sick sinus syndrome

1.6

20.0

548

2590

TQW75

NOMESCO Finland

Skin pressure therapy

13.2

19.9

45599

ICD-8 Finland

Haemorrhoids

1.7

19.9

434

1927

K59.0

ICD-10 Finland

Constipation

1.4

19.9

898

4737

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.3

19.9

1261

7055

D03BA02

ATC

collagenase; topical

3.7

19.9

184

R03BA05

ATC

fluticasone; inhalant

1.2

19.8

3672

23394

Z00.8

ICD-10 Finland

Other general examinations

1.3

19.8

1321

7447

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.4

19.8

864

4526

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.1

19.8

225

793

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.5

19.7

738

3747

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.4

19.7

834

4342

H13

ICPC

Plugged feeling ear

1.2

19.6

3350

21183

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

1.7

19.6

407

1783

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.5

19.6

622

3045

D06

ICPC

Abdominal pain localized other

1.3

19.6

1311

7399

S17

ICPC

Abrasion/scratch/blister

1.8

19.5

360

1518

S16

ICPC

Bruise/contusion

1.7

19.5

454

2054

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

2.0

19.5

267

1014

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

19.5

1149

6353

I82.29

ICD-10 Finland

Embolism and thrombosis of vena cava

+∞

19.5

PHG79

NOMESCO Finland

Intraluminal laser vein occlusion of anterior saphenous vein

+∞

19.5

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

1.6

19.3

559

2677

K30

ICD-10 Finland

Functional dyspepsia

1.3

19.3

1805

10676

Z50.1

ICD-10 Finland

Other physical therapy

1.4

19.2

933

4989

SPAT1281

SPAT

Other administrative function

1.3

19.2

1489

8585

E000002

ATC

1.2

19.2

2272

13825

SPAT1285

SPAT

Provision of consultation response

1.4

19.2

916

4884

SPAT1304

SPAT

Counselling and guidance related to ageing

1.4

19.1

893

4738

A97

ICPC

No disease

1.2

19.1

2791

17374

U02

ICPC

Urinary frequency/urgency

1.3

19.0

1749

10321

M03BC51

ATC

orphenadrine, combinations; systemic

1.1

19.0

6252

41715

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

1.8

19.0

366

1568

NF1DA

NOMESCO Finland

X-ray of hips

1.8

19.0

331

1372

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.6

19.0

463

2124

R20.2

ICD-10 Finland

Paraesthesia of skin

1.3

18.9

1267

7148

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.3

18.8

1280

7240

L04AA01

ATC

[U] ciclosporin; systemic

1.9

18.8

267

1029

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.3

18.8

1709

10072

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.2

18.8

3562

22740

A03

ICPC

Fever

1.2

18.8

3321

21068

S11

ICPC

Skin infection post-traumatic

1.9

18.7

269

1043

I87

ICD-10 Finland

Other disorders of veins

9.7

18.7

R03BA02

ATC

budesonide; inhalant

1.2

18.7

3506

22360

J01CA08

ATC

pivmecillinam; oral

1.1

18.6

6001

39970

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.3

18.6

2005

12065

Z01.9

ICD-10 Finland

Special examination, unspecified

1.4

18.6

934

5026

196

Kela drug reimbursment

Paricalcitol and cinacalcet

2.9

18.6

118

305

L01

ICPC

Neck symptom/complaint

1.2

18.6

2397

14724

J96.1

ICD-10 Finland

Chronic respiratory failure

1.7

18.6

390

1714

U07

ICPC

Urine symptom/complaint other

1.4

18.5

847

4481

K92

ICPC

Atherosclerosis/periph vascular dis

2.1

18.5

227

827

M23.8

ICD-10 Finland

Other internal derangements of knee

1.5

18.5

696

3541

S91.3

ICD-10 Finland

Open wound of other parts of foot

1.6

18.5

471

2187

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

1.7

18.4

363

1566

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

1.5

18.4

596

2933

EBA00

NOMESCO Finland

Extraction of tooth

1.1

18.4

7437

50304

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.5

18.4

738

3806

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

18.4

4153

26916

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.4

18.3

965

5234

N43.3

ICD-10 Finland

Hydrocele, unspecified

1.6

18.3

455

2098

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.4

18.3

876

4670

J45

ICD-10 Finland

Asthma

1.3

18.2

1693

10002

SPAT1202

SPAT

Intra-articular injection

1.6

18.2

436

1989

V03AE02

ATC

sevelamer; oral

2.7

18.2

131

366

M54

ICD-10 Finland

Dorsalgia

1.2

18.1

2195

13392

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.7

18.1

401

1792

A09AA02

ATC

multienzymes (lipase, protease etc.)

1.8

18.0

348

1491

M01AB55

ATC

diclofenac, combinations; oral

1.4

18.0

1030

5667

B01AX06

ATC

[U] rivaroxaban; oral

1.8

18.0

300

1224

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.3

18.0

1142

6393

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.4

17.9

1033

5692

N30.9

ICD-10 Finland

Cystitis, unspecified

1.4

17.9

772

4036

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.3

17.9

1907

11461

D01

ICPC

Abdominal pain/cramps general

1.3

17.9

1780

10607

E66.0

ICD-10 Finland

Obesity due to excess calories

2.2

17.9

192

659

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

17.9

1617

9521

D97

ICPC

Liver disease NOS

3.0

17.9

108

270

H29

ICPC

Ear symptom/complaint other

1.3

17.9

1657

9788

I89.8

ICD-10 Finland

Other specified noninfective disorders of lymphatic vessels and lymph nodes

20.9

17.8

UJK02

NOMESCO Finland

ERCP

1.7

17.8

410

1850

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

1.6

17.8

480

2260

R10.0

ICD-10 Finland

Acute abdomen

1.5

17.8

582

2872

A04AD12

ATC

aprepitant; systemic

1.8

17.7

311

1292

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1.5

17.7

649

3283

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.3

17.7

1319

7563

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.3

17.7

1608

9476

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.4

17.7

1062

5890

LCA06

NOMESCO Finland

Biopsy of endometrium

1.3

17.7

1733

10312

2891A

ICD-9 Finland

Other diseases of blood and blood-forming organs, Chronic lymphadenitis

+∞

17.6

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.5

17.5

644

3261

S20.2

ICD-10 Finland

Contusion of thorax

1.4

17.5

932

5066

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

1.7

17.5

407

1840

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.5

17.5

724

3755

A06AH03

ATC

naloxegol; oral

2.1

17.5

196

685

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.5

17.5

602

3004

N81.1

ICD-10 Finland

Cystocele

1.7

17.5

359

1570

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

2.4

17.5

153

478

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.2

17.4

191

662

-56

ICPC

Dressing/pressure/compress/tamponade

1.8

17.4

301

1244

SPAT1360

SPAT

Extensive global examination

1.3

17.4

1293

7408

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

2.5

17.4

140

417

G44.2

ICD-10 Finland

Tension-type headache

1.2

17.4

2405

14878

D02AX

ATC

Other emollients and protectives

1.5

17.4

533

2589

R32

ICD-10 Finland

Unspecified urinary incontinence

1.8

17.4

308

1283

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.5

17.4

636

3218

K29.6

ICD-10 Finland

Other gastritis

2.1

17.4

195

683

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.6

17.3

478

2264

J01DA06

ATC

[U] cefuroxime; systemic

1.2

17.3

2967

18755

PG1UT

NOMESCO Finland

Percutaneous aspiration throbectomy

3.5

17.3

179

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3013707) Erythrocyte sedimentation rate by Westergren method

38475

218935

1.44

323.31

4.7

3.9

13.2

11.8

mm/h

62.62

35838

203199

(3013650) Neutrophils [#/volume] in Blood by Automated count

30887

169090

1.41

320.94

10.3

8.9

4.1

e9/l

4.46

27258

147709

(4268621)

1267

2399

3.49

315.20

2.4

2.3

—

(3042936) Bacteria identified in Isolate by Culture

9270

40095

1.60

314.62

2.4

2.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

35705

200933

1.42

313.31

5.0

4.1

—

(3013115) Eosinophils [#/volume] in Blood

28088

151643

1.40

312.45

6.8

6.0

0.2

e9/l

5.74

24839

133400

(3006315) Basophils [#/volume] in Blood

27310

146857

1.40

309.80

6.6

5.8

0.0

e9/l

5.48

23806

127304

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

16410

60371

2.08

307.65

2.0

1.7

1.4

1.1

mg/l

16.54

12918

45948

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

28698

151758

1.46

307.65

7.6

5.9

11.9

11.3

umol/l

9.39

27349

143751

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

2031

3208

4.24

307.65

1.1

117.8

118.5

0.33

1776

2963

(3031040) Bacteria [#/volume] in Urine by Automated count

34619

189670

1.48

307.65

5.1

4.2

1381.1

1303.6

e6/l

0.11

501

2695

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

2057

3353

4.11

307.65

1.1

—

(3032080) INR in Blood by Coagulation assay

24307

114908

1.66

307.65

11.9

8.1

1.3

1.2

inr

3.99

7081

33060

(3036489) Thrombin time

3699

9557

2.62

307.65

2.3

2.0

21.7

21.4

1.47

3063

8475

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1882

3532

3.55

307.65

1.3

1.2

4.0

3.8

u/ml

0.29

858

1532

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1944

3611

3.59

307.65

1.3

1.2

3.7

3.5

u/ml

0.13

676

1221

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2933

7187

2.75

307.65

2.8

2.4

191.2

187.8

1.12

2748

6829

(4306422)

2078

3354

4.15

307.65

1.2

—

(3023368) Bacteria identified in Blood by Culture

16557

76336

1.58

307.65

5.2

4.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

27387

142738

1.48

307.65

7.8

6.5

1.2

mmol/l

0.56

23067

120401

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

3371

7694

2.97

307.65

2.5

2.2

93.3

91.4

4.10

3063

7230

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

25111

128970

1.48

307.65

7.0

5.9

1.2

mmol/l

0.70

22869

116886

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

16988

78171

1.59

307.65

3.2

2.9

1468.5

1386.0

ng/l

1.19

14583

66421

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

1520

2400

4.21

307.65

1.1

95.2

96.6

0.98

1388

2283

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

40141

227489

1.50

307.65

9.4

7.2

79.8

77.8

u/l

12.62

37994

214381

(3022217) INR in Platelet poor plasma by Coagulation assay

9183

35737

1.80

307.65

28.9

22.3

1.4

1.3

inr

7.06

1223

5169

(3024561) Albumin [Mass/volume] in Serum or Plasma

24255

124798

1.46

307.65

6.0

4.6

34.9

35.7

g/l

81.35

22575

115713

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2956

8539

2.32

307.65

3.6

3.0

0.3

u/ml

0.25

1826

4720

(3013826) Glucose [Moles/volume] in Serum or Plasma

31417

170444

1.44

307.65

5.6

4.6

6.7

mmol/l

7.11

29837

159095

(3001604) Monocytes [#/volume] in Blood

27178

146148

1.40

307.28

6.6

5.8

0.6

e9/l

3.67

23719

126684

(42870588) Differential panel, method unspecified - Blood

19489

98861

1.43

306.80

6.6

5.9

—

(3019198) Lymphocytes [#/volume] in Blood

27822

150545

1.40

300.59

6.6

5.8

1.8

1.9

e9/l

13.82

24638

132865

(3026008) Bacteria identified in Urine by Culture

16641

82296

1.45

298.47

3.4

2.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

7875

33263

1.63

292.10

2.1

1.7

—

(3006504) Eosinophils/100 leukocytes in Blood

25564

137197

1.39

283.38

6.9

5.9

2.9

0.28

23950

127969

(3019069) Monocytes/100 leukocytes in Blood

25668

137961

1.38

281.13

7.2

6.2

8.7

8.6

6.65

24156

129332

(3033658) Prothrombin time (PT) actual/Normal

15075

73853

1.45

280.47

5.4

3.7

87.3

91.1

52.10

14625

72039

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

25368

136209

1.38

278.64

4.5

3.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

21041

109626

1.39

275.97

4.1

3.4

57.8

66.0

ng/l

0.31

14739

72180

(3022096) Basophils/100 leukocytes in Blood

24846

133102

1.38

275.61

6.9

6.0

0.7

0.07

23274

124210

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

9922

44851

1.53

273.49

2.0

1.8

—

(3002030) Lymphocytes/100 leukocytes in Blood

26141

141922

1.37

261.85

7.0

6.0

27.2

28.0

24.00

24474

132328

(3004789) Transferrin [Mass/volume] in Serum or Plasma

9236

41524

1.53

259.33

2.8

2.4

2.3

g/l

4.43

8507

38396

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

14445

71059

1.43

258.64

2.5

2.2

3.1

2.9

mg/l

19.87

12451

60658

(3022948) Iron [Moles/volume] in Serum or Plasma

9866

45125

1.51

255.30

2.8

2.4

12.6

13.8

umol/l

1.88

9131

41816

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

8660

38529

1.55

254.40

2.9

2.5

22.2

23.0

4.74

7424

32938

(3018010) Neutrophils/100 leukocytes in Blood

25739

139836

1.36

253.52

6.7

5.8

57.8

57.3

7.66

24166

130949

(3044640) Blood type and Crossmatch panel - Blood

17825

91262

1.39

253.14

2.8

2.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

9516

43360

1.51

250.04

2.7

2.0

30.4

29.7

20.30

9226

42093

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

17949

92210

1.39

248.69

2.9

2.5

56.4

58.8

u/l

4.69

16625

85140

(3018418) pH of Serum or Plasma

16596

84455

1.39

241.57

4.8

4.0

7.4

0.55

3417

15925

(3012095) Magnesium [Moles/volume] in Serum or Plasma

9974

46234

1.49

240.13

3.9

3.3

0.8

mmol/l

7.10

9330

43099

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2510

7859

2.13

238.47

3.3

2.4

3.5

3.6

g/l

2.90

2395

7492

(3019550) Sodium [Moles/volume] in Serum or Plasma

50179

305965

1.56

237.28

21.2

15.1

139.6

139.7

mmol/l

2.10

49133

298327

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

49149

298451

1.52

234.98

19.3

13.3

23.4

23.8

mg/l

1.28

41073

235071

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6213

26060

1.62

232.72

2.8

2.1

0.2

g/l

43.36

5731

24259

(3023103) Potassium [Moles/volume] in Serum or Plasma

50270

306935

1.55

231.41

21.4

15.3

4.0

mmol/l

20.65

49170

298741

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

17002

87660

1.37

224.82

2.3

2.1

195.3

209.8

u/l

1.34

15981

82254

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

750

1249

3.95

222.44

1.3

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

13778

68927

1.40

216.88

2.7

2.3

—

(3002582) Erythrocytes [#/volume] in Urine

16848

87199

1.37

215.28

3.7

3.1

85.0

92.4

e6/l

0.24

13227

66691

(3015377) Calcium [Moles/volume] in Serum or Plasma

18385

96514

1.35

214.27

3.7

3.3

2.3

2.4

mmol/l

5.21

16070

84469

(3018095) Leukocytes [#/volume] in Urine

19226

101879

1.34

209.38

4.3

3.6

92.3

98.3

e6/l

0.41

14145

72038

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

22020

119088

1.33

208.69

2.4

2.2

77.6

838.9

nmol/l

0.50

19831

107610

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

21791

117753

1.33

207.21

2.1

1.9

95.9

pmol/l

0.01

11687

62011

(3030467) Casts [#/volume] in Urine by Automated count

15493

79622

1.37

204.60

3.6

3.1

0.4

e6/l

0.03

11903

59655

(3000850) Epithelial cells [#/volume] in Urine

12166

60093

1.40

204.06

2.9

2.5

5.3

5.4

e6/l

0.42

10721

52479

(3019309) Folate [Moles/volume] in Red Blood Cells

10775

52237

1.42

200.38

1.9

1.7

1177.2

1162.0

nmol/l

0.89

8202

39704

(3021960) Folate [Moles/volume] in Serum or Plasma

12853

64609

1.38

192.36

1.6

1.5

19.9

20.4

nmol/l

3.13

11095

55670

(36304419) Bacteria [Presence] in Urine

15024

77587

1.35

189.14

3.5

3.0

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7975

36954

1.47

187.05

6.9

5.8

1.0

mmol/l

5.24

7464

34423

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

604

973

4.07

186.95

1.1

1.0

94.9

100.1

2.82

458

799

(3001122) Ferritin [Mass/volume] in Serum or Plasma

23018

126601

1.31

186.31

3.2

2.8

135.7

128.7

ug/l

2.92

21328

117624

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

7051

31994

1.50

183.17

4.3

4.2

244.9

242.3

u/l

0.73

6632

30264

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4812

20149

1.61

178.62

1.8

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6783

30719

1.50

177.38

1.9

1.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

6843

31134

1.49

174.76

2.8

2.5

1.8

1.7

8.23

6000

27586

(3020779) Urea [Moles/volume] in Serum or Plasma

5682

24866

1.54

174.17

8.8

7.3

10.4

9.7

mmol/l

9.87

5408

23613

(3035350) Ketones [Presence] in Urine by Test strip

25475

143021

1.29

171.09

4.1

3.5

0.0

estimate

2.80

5061

26031

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6764

30878

1.48

169.48

1.9

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

38319

226943

1.30

168.19

4.2

3.9

14.8

14.7

pmol/l

12.35

35061

207545

(3021601) Nitrite [Presence] in Urine by Test strip

25489

143389

1.28

166.86

5.5

4.7

0.0

estimate

0.50

5131

26704

(3009261) Glucose [Presence] in Urine by Test strip

25737

144981

1.28

166.57

4.1

3.5

0.0

estimate

0.15

5012

25836

(3026493) Urate [Moles/volume] in Serum or Plasma

14976

78499

1.33

165.96

3.0

2.5

3672.0

4395.5

umol/l

1.46

12958

68541

(3023183) Ammonium ion [Moles/volume] in Plasma

1773

5606

2.09

163.37

4.4

2.3

37.5

32.8

umol/l

10.19

1546

4696

(3037522) Nuclear Ab [Titer] in Serum

8358

40058

1.42

161.34

1.4

1.3

546.4

535.2

titre

0.20

1803

8052

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

44881

272292

1.34

160.61

5.1

4.6

1.9

2.1

mu/l

4.38

41342

250513

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

710

1444

3.23

158.33

1.2

1.1

ratio

0.36

239

514

(3026782) Osmolality of Urine

11118

56089

1.36

157.51

3.1

2.7

534.8

550.3

mosm/kgh2o

9.72

9566

47770

(3013512) EKG study

15527

82350

1.31

156.24

4.3

3.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6222

28455

1.48

153.31

4.0

3.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

10963

55451

1.36

151.92

4.0

3.6

335.4

554.9

ng/l

5.98

8528

41888

(3000494) Fungus identified in Specimen by Culture

7088

33439

1.43

148.04

1.5

1.4

—

(40768804) Tissue Pathology biopsy report

21618

120624

1.27

143.17

2.2

2.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1227

3523

2.29

142.79

3.2

2.4

938.8

707.1

u/ml

0.12

1206

3394

(3020630) Protein [Mass/volume] in Serum or Plasma

5076

22622

1.51

141.19

2.6

2.5

66.1

66.6

g/l

4.52

4598

20596

(3023520) Reticulocytes [#/volume] in Blood

5130

22975

1.50

139.27

3.0

2.5

70.4

69.2

e9/l

1.27

3859

17395

(3015736) pH of Urine

20049

111133

1.27

138.96

3.8

3.3

5.5

5.7

—

(40758558) Short blood count panel - Blood

13916

73838

1.30

135.48

7.8

6.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5069

22997

1.48

128.55

3.1

2.8

213.0

205.2

ng/l

0.50

4593

20925

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

10080

51470

1.33

128.02

3.3

3.0

2.5

2.4

mmol/l

6.86

8847

44796

(3003396) Base excess in Arterial blood by calculation

6765

32426

1.41

127.68

7.6

7.3

1.1

1.0

mmol/l

0.95

5388

25474

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

6761

32426

1.41

127.12

7.6

7.3

5.1

kpa

0.26

6432

30923

(3027801) Oxygen [Partial pressure] in Arterial blood

6757

32407

1.41

127.04

7.6

7.3

12.0

12.5

kpa

9.61

6429

30891

(3004588) Protein electrophoresis panel - Serum or Plasma

4216

18493

1.52

125.64

2.4

2.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

9645

49157

1.33

123.48

3.1

2.7

1.2

e6/l

0.03

5587

28009

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3728

15985

1.55

123.03

1.8

1.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

544

1104

3.23

121.79

1.2

1.1

18.9

10.0

u/ml

0.47

102

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

45779

281338

1.30

120.59

17.1

12.4

79.8

82.0

ml/min/173m2

89.79

39006

232257

(3005719) IgG [Mass/volume] in Serum or Plasma

4719

21367

1.48

120.43

3.0

2.6

10.9

10.5

g/l

4.94

4346

19527

(40768797) Stomach Pathology biopsy report

8053

40081

1.36

120.26

1.3

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

17694

97942

1.25

118.75

4.0

3.1

33.8

33.9

u/l

0.03

16816

92832

(3021589) Normoblasts [#/volume] in Blood

22823

130159

1.24

116.24

11.9

9.2

0.0

e9/l

0.65

18822

106915

(3020564) Creatinine [Moles/volume] in Serum or Plasma

50946

318366

1.39

115.65

21.5

15.4

78.8

77.4

umol/l

13.75

50925

318197

(3016502) Oxygen saturation in Arterial blood

6060

28976

1.40

115.06

7.9

7.7

95.6

95.7

0.22

5840

27885

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

6817

33298

1.38

113.94

3.8

2.6

9.9

8.3

umol/l

4.96

5989

28783

(3028026) IgM [Mass/volume] in Serum or Plasma

3776

16538

1.52

112.82

1.9

1.3

g/l

0.73

3450

15065

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2156

8219

1.74

112.74

1.9

1.7

—

(3009343) pH of Capillary blood

3919

17339

1.51

111.60

4.1

3.4

7.4

0.91

583

2245

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3962

17575

1.50

111.42

4.2

3.4

5.2

5.1

kpa

1.65

3651

16238

(3014576) Chloride [Moles/volume] in Serum or Plasma

7259

35934

1.36

111.39

7.9

7.1

104.5

mmol/l

0.25

7081

35174

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3791

16735

1.51

109.01

4.1

3.4

1.8

1.7

mmol/l

1.73

2857

12292

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

8937

45766

1.32

109.01

3.3

2.8

2.6

2.8

e6/l

0.65

4927

24779

(3023487) Leukocytes [#/volume] in Peritoneal fluid

423

789

3.51

107.56

2.4

1.7

2755.4

3991.6

e6/l

0.26

297

529

(3044889) 12 lead EKG panel

34727

207757

1.22

107.33

4.1

3.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

46609

288141

1.29

107.00

4.8

4.4

5.9

mmol/l

1.49

42678

264675

(3014111) Lactate [Moles/volume] in Serum or Plasma

5275

24920

1.42

106.76

7.5

7.1

1.4

1.3

mmol/l

1.11

5087

23991

(3019225) pH of Specimen

5754

27621

1.40

106.18

4.7

4.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

9809

51110

1.30

104.99

1.3

33.7

36.5

iu/ml

0.48

3066

16200

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

6038

29288

1.38

104.60

4.1

4.0

20.5

25.9

ug/l

0.73

4902

23437

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

44468

273573

1.26

103.78

6.1

5.6

39.8

39.7

mmol/mol

2.02

41212

254209

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4495

20761

1.44

102.72

4.3

3.8

97.4

90.8

ng/l

3.84

3893

17931

(40761511) CBC panel - Blood by Automated count

49906

311782

1.33

101.94

17.6

12.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2636

10918

1.60

100.30

2.2

1.9

2.5

2.2

ug/l

0.40

2327

9626

(3000991) Gas panel - Venous blood

4999

23638

1.41

100.28

9.3

8.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5551

26745

1.39

99.82

8.4

8.1

120.7

121.9

g/l

4.27

5364

25781

(3034426) Prothrombin time (PT)

420

825

3.33

98.97

1.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5415

26035

1.39

98.51

4.7

3.8

5.9

5.8

kpa

1.38

5247

25281

(3033799) Differential panel - Peritoneal fluid

373

682

3.58

97.64

2.4

1.7

—

(3002032) Base excess in Venous blood by calculation

5395

25968

1.39

97.43

4.8

3.8

1.9

1.8

mmol/l

0.86

4481

21210

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

50890

319180

1.35

97.24

12.8

9.9

25.9

26.8

u/l

13.59

49304

308455

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

377

702

3.51

96.16

2.3

1.6

11870.3

11014.1

e6/l

0.06

223

361

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2873

12265

1.55

95.95

1.6

1.5

13.8

14.8

u/ml

0.15

322

(3012544) pH of Venous blood

5567

27000

1.38

95.94

4.7

3.8

7.4

0.11

146

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

9209

48140

1.29

94.94

1.3

9.4

12.1

u/ml

3.27

3487

19124

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

11364

61024

1.26

94.32

1.7

32698306.8

35332598.3

pmol/l

0.17

9337

50863

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

385

744

3.38

93.01

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

317

536

3.87

92.39

1.7

1.2

11.9

14.3

g/l

3.89

237

413

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1966

7719

1.68

92.16

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2900

12567

1.53

90.40

1.8

1.7

1.5

1.6

g/l

1.65

2485

10706

(3034770) Mitochondria Ab [Titer] in Serum

1959

7739

1.67

89.71

1.3

1.2

996.2

923.3

titre

0.17

229

(3029937) Albumin [Presence] in Urine by Test strip

13938

77006

1.24

89.01

4.6

3.9

0.0

estimate

0.85

4912

25583

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2995

13125

1.51

88.57

5.1

4.2

24.2

24.1

mmol/l

0.67

2703

11740

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

397

810

3.21

88.28

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

1970

7850

1.66

87.27

1.3

1.2

106.7

129.0

titre

0.78

211

682

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3619

16534

1.45

86.99

1.6

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1410

5150

1.80

85.04

1.7

1.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

574

1475

2.55

84.77

3.4

1.8

90.0

101.1

9.71

540

1377

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1514

5660

1.76

84.48

6.4

5.7

3069.5

1257.4

iu/ml

0.35

267

819

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

5441

26846

1.35

83.41

2.8

2.5

49.4

42.9

u/l

0.21

4707

22946

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

19462

111726

1.20

83.34

4.4

3.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2313

9731

1.57

82.09

2.4

2.3

390.8

554.7

ug/l

2.07

2179

9099

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2073

8528

1.60

80.83

1.8

1.6

0.2

g/l

0.77

1969

8077

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2120

8793

1.59

79.90

1.8

1.6

1.2

g/l

0.55

2018

8358

(3044007) Cell count panel - Peritoneal fluid

329

640

3.36

78.79

2.3

1.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3657

17086

1.42

77.58

7.7

7.2

24.8

mmol/l

0.36

3631

16917

(3011397) Hemoglobin [Presence] in Urine by Test strip

12144

66953

1.23

77.00

4.0

3.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5274

26237

1.34

76.15

2.2

2.3

364.2

373.2

nmol/l

2.41

4891

24149

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

4736

23232

1.36

74.93

4.7

3.7

1.2

mmol/l

2.44

4208

20279

(3014007) Fractional oxyhemoglobin in Arterial blood

3777

17866

1.40

74.59

9.5

9.4

93.8

93.9

0.74

3765

17800

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2250

9619

1.54

74.31

1.7

1.6

307.4

259.9

titre

0.33

396

(3002331) Protein [Mass/volume] in Peritoneal fluid

273

487

3.66

74.12

1.4

1.3

24.1

41.1

g/l

0.83

193

395

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4888

24136

1.35

74.04

2.4

2.3

7.1

7.5

ug/l

0.45

4196

21048

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3238

14940

1.44

73.46

9.5

24.3

mmol/l

0.16

3003

13922

(3022313) Gas panel - Capillary blood

2790

12521

1.47

73.14

4.4

3.5

—

(3019060) Gas panel - Arterial blood

3902

18644

1.39

72.56

5.0

4.9

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1882

7783

1.59

71.72

1.6

1.4

17.4

13.5

iu/ml

0.48

187

(3007164) IgA [Mass/volume] in Serum or Plasma

10130

55158

1.24

71.38

1.6

1.4

2.7

2.4

g/l

17.54

6312

33924

(40768443) Skin Pathology biopsy report

2774

12503

1.47

71.11

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3740

17812

1.39

70.84

9.5

9.3

0.7

0.14

3714

17700

(3017181) Myelocytes/100 leukocytes in Blood

4933

24565

1.34

70.43

4.4

4.0

1.0

0.9

0.63

1569

6742

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3738

17854

1.39

69.55

9.4

9.2

1.4

0.65

3709

17729

(3022145) Colonoscopy Study observation

6398

33109

1.29

69.09

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2280

9939

1.51

68.78

3.6

3.4

5743.8

1012.9

u/ml

0.97

1964

8515

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2596

11639

1.47

68.30

2.1

1.9

—

(3024354) Oxygen [Partial pressure] in Venous blood

4345

21329

1.35

68.11

4.0

3.2

4.7

4.6

kpa

0.88

4184

20627

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2372

10479

1.49

67.11

2.4

2.2

7.3

7.4

g/l

0.24

1771

7802

(3021440) Promyelocytes/100 leukocytes in Blood

4690

23358

1.33

66.71

4.5

4.1

0.1

0.53

1466

6230

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2366

10469

1.49

66.42

2.4

2.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2361

10451

1.49

66.15

2.4

2.2

3.9

3.8

g/l

0.74

1688

7445

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1995

8533

1.54

65.65

3.3

38.2

45.0

mg/l

1.81

1582

6929

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2423

10802

1.48

65.54

4.6

3.7

24.9

24.8

mmol/l

1.12

2231

9977

(3034860) Kappa light chains.free [Mass/volume] in Serum

1996

8547

1.54

65.34

3.3

53.8

70.1

mg/l

0.97

1584

6934

(3002179) Metamyelocytes/100 leukocytes in Blood

4487

22267

1.34

65.33

4.3

3.9

0.7

0.6

1.41

1145

4840

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1023

3678

1.83

64.94

6.3

6.2

11.5

mg/l

0.03

929

3382

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1939

8291

1.54

63.88

3.2

3.3

1.9

3.8

ratio

1.39

156

647

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1522

6151

1.63

63.67

1.7

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2232

9843

1.50

63.65

2.4

2.2

3.1

g/l

1.18

1718

7654

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1031

3744

1.81

63.37

1.1

1.6

1.5

g/l

4.98

937

3384

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4703

23614

1.32

63.06

3.0

2.6

64.2

66.7

ml/min/173m2

4.04

1989

9232

(40760892) CBC W Ordered Manual Differential panel - Blood

11808

66003

1.21

63.06

5.0

4.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1600

6565

1.60

62.94

1.7

1.6

—

(40768441) Liver Pathology biopsy report

630

1953

2.11

61.06

1.8

1.3

—

(3025159) Blasts/100 leukocytes in Blood

4402

22013

1.33

60.61

4.5

4.1

0.3

0.2

0.43

1262

5240

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2029

8885

1.50

59.82

2.4

0.9

g/l

0.04

1743

7616

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2197

9790

1.48

59.48

2.4

2.2

10.5

10.2

g/l

2.18

1834

8173

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

11308

63250

1.20

59.38

1.3

1.5

1.7

u/ml

1.51

3081

17328

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1907

8255

1.52

59.35

1.4

266.1

274.2

ug/g

0.71

1124

4774

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2354

10647

1.46

59.08

2.0

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1537

6346

1.59

58.91

1.7

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1607

6718

1.57

58.44

1.7

1.6

14790.6

13080.0

e6/l

0.68

1149

4910

(3037756) Immunofixation for Serum or Plasma

1390

5612

1.63

58.37

1.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

257

523

3.21

57.59

1.2

—

(3010421) pH of Blood

1748

7481

1.54

57.31

4.6

3.8

7.4

0.37

1508

6335

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3196

15362

1.38

56.87

10.1

9.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

47965

301892

1.21

56.46

5.1

4.8

2.7

2.8

mmol/l

32.20

44242

279948

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1747

7502

1.53

56.40

4.2

3.1

1.7

1.5

mg/l

13.48

1609

6888

(4035726)

4952

25419

1.29

56.15

1.4

—

(3021788) Differential panel - Synovial fluid

1273

5076

1.65

56.14

1.6

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1123

4343

1.70

55.58

3.1

2.8

2739.2

7492.0

u/ml

0.69

222

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

33112

202407

1.15

55.44

3.8

3.0

54.4

48.0

u/l

22.49

30984

189598

(3041096) Erythrocytes [Presence] in Urine by Automated

13724

78512

1.18

55.24

3.8

3.1

—

(21494755) Public health laboratory ask at order entry panel

3785

31911

0.76

55.16

1.4

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3614

17792

1.34

55.14

7.4

7.1

24.7

24.6

mmol/l

1.45

3385

16570

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2109

9501

1.46

53.98

2.8

2.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1739

7559

1.51

53.06

1.5

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

1543

6534

1.55

53.04

4.7

3.8

8.5

8.6

kpa

1.31

1517

6367

(3013290) Carbon dioxide [Partial pressure] in Blood

1534

6496

1.55

52.73

4.7

3.8

5.0

kpa

0.49

1508

6330

(3012501) Base excess in Blood by calculation

1533

6495

1.55

52.58

4.7

3.8

2.7

2.5

mmol/l

1.75

1090

4356

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

392

1058

2.42

52.53

3.4

2.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

6573

35180

1.24

52.45

4.5

4.4

32.5

32.0

3.74

4712

24335

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1833

8104

1.49

51.54

2.2

37.0

37.9

g/l

7.72

1580

6955

(1616796) Gas panel - Central venous blood

1513

6423

1.55

51.43

4.3

3.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

422

1190

2.32

51.39

29.7

27.9

120.1

115.9

ug/l

0.54

353

987

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1790

7880

1.49

51.39

2.3

2.2

0.0

g/l

0.03

1632

7187

(40767503) Oxygen content in Capillary blood by calculation

1438

6038

1.56

51.30

2.9

2.5

16.2

16.5

1.94

761

3128

(3019150) Specific gravity of Urine by Refractometry

11084

62587

1.19

51.25

4.5

3.8

1.0

kg/l

0.55

1716

9355

(40760888) Immunoglobulin light chains.free panel - Serum

1513

6431

1.55

51.15

3.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

45387

284779

1.18

51.14

4.1

3.9

1.3

mmol/l

19.18

41619

262842

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1183

4745

1.64

51.00

1.7

—

(3037121) Protein [Mass/volume] in Urine

2090

9522

1.45

50.41

3.3

3.1

0.3

g/l

0.23

946

4226

(3007461) Platelets [#/volume] in Blood

52402

333561

1.27

50.32

27.6

19.6

245.7

252.7

e9/l

103.67

51310

324863

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1640

7135

1.51

49.82

3.3

2.9

24.8

24.7

mmol/l

0.60

1441

6281

(3028626) Oxygen [Partial pressure] in Capillary blood

1474

6269

1.54

49.70

3.6

2.9

8.2

kpa

0.06

1370

5818

(40761535) Cells panel - Urine sediment

4565

23541

1.29

49.64

3.8

3.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

47120

296781

1.19

49.60

4.6

4.3

4.6

4.7

mmol/l

16.89

43727

276728

(3024731) MCV [Entitic volume]

52430

333826

1.27

49.54

27.4

19.5

91.4

90.9

90.97

51762

329139

(3035941) MCH [Entitic mass]

52423

333779

1.27

49.50

27.4

19.5

30.3

0.28

51752

329106

(3010813) Leukocytes [#/volume] in Blood

52438

333903

1.27

49.30

27.6

19.6

6.6

6.7

e9/l

14.83

51209

324232

(3028271) Lactate [Moles/volume] in Capillary blood

1114

4442

1.65

49.16

2.0

1.8

1.7

mmol/l

0.89

1092

4332

(3026361) Erythrocytes [#/volume] in Blood

52428

333849

1.27

49.09

27.5

19.6

4.4

4.5

e12/l

263.81

51177

324197

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1660

7274

1.50

48.73

2.3

0.0

g/l

2.58

1509

6605

(3000963) Hemoglobin [Mass/volume] in Blood

52437

333944

1.27

48.73

27.7

19.7

133.4

136.1

g/l

308.97

51774

329277

(40761536) Microorganisms panel - Urine sediment

4692

24344

1.28

48.56

4.8

3.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

46790

294642

1.19

48.49

4.6

4.3

1.5

mmol/l

15.92

43192

273501

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1634

7173

1.50

47.55

2.3

0.0

g/l

0.00

1503

6587

(3052851) Hemolysis interference index of Serum or Plasma

1905

8694

1.44

45.50

3.6

3.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1158

4768

1.59

44.93

3.1

3.0

0.8

nmol/l

0.18

878

3663

(3002256) Pathology report gross observation

7099

38913

1.21

44.45

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

6017

32437

1.23

44.37

1.7

1.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1944

8963

1.43

43.92

1.9

1.8

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1397

6039

1.52

43.74

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1396

6037

1.52

43.63

1.4

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

6503

35445

1.22

42.99

2.3

139.2

134.9

ug/g

0.39

5131

27953

(3044941) Cell count panel - Synovial fluid

1055

4296

1.61

42.86

1.5

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1309

5611

1.53

42.62

3.5

3.2

679.3

815.3

u/ml

0.20

1194

5086

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1474

6489

1.49

42.32

2.4

2.1

128.1

130.8

g/l

3.33

1094

4690

(3004809) Band form neutrophils/100 leukocytes in Blood

1096

4523

1.59

42.14

3.6

3.2

1.4

1.5

0.25

878

3471

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2409

11615

1.37

41.82

1.3

1.2

1.3

0.8

u/ml

1.26

223

1018

(3021901) Oxygen saturation in Capillary blood

1225

5217

1.54

41.09

3.1

2.7

—

(3018405) Lactate [Moles/volume] in Arterial blood

2093

9892

1.39

41.04

4.4

4.2

1.4

mmol/l

0.38

2055

9716

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

987

9993

0.64

40.84

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

934

3736

1.64

40.78

1.6

1.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

905

3597

1.65

40.51

2.0

1.8

89.5

89.7

0.42

896

3536

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1397

6140

1.49

40.43

1.5

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

404

1240

2.13

40.36

38.4

34.5

7.3

7.4

ug/l

0.52

372

1114

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

620

2249

1.80

38.44

1.3

1.2

102.2

181.7

titre

1.09

(3019174) dRVVT (LA screen)

122

196

4.06

38.31

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

620

2256

1.80

38.05

1.3

1.2

182.6

176.0

titre

0.07

112

368

(3025941) Bacteria identified in Stool by Culture

3303

16915

1.29

37.57

1.3

—

(3012516) Albumin [Mass/volume] in Urine

14599

85873

1.14

37.55

3.4

3.2

552.0

394.4

mg/l

2.83

9199

54477

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

787

3077

1.67

37.54

1.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1607

7370

1.43

37.38

1.3

7.5

5.8

u/ml

0.23

185

752

(3044009) aPTT.lupus sensitive (LA screen)

123

204

3.93

37.10

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1271

5581

1.49

36.98

1.3

1.2

101.3

143.8

titre

0.58

105

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1353

6021

1.47

36.85

1.3

1.2

5.9

u/ml

0.00

105

450

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1623

7482

1.42

36.70

1.3

10.0

7.1

u/ml

0.88

268

1171

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2993

15179

1.30

36.65

2.5

2.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1344

5985

1.47

36.48

1.3

1.2

9.4

16.1

u/ml

0.39

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1733

8102

1.40

36.20

1.3

39.6

34.4

u/ml

0.34

118

474

(3030905) Polymorphonuclear cells [#/volume] in Blood

1299

5763

1.48

35.93

3.4

3.2

4.2

4.1

e9/l

0.31

1293

5753

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2493

12361

1.33

35.92

2.1

2.0

39.4

u/l

0.02

2193

11025

(3020682) Albumin/Creatinine [Ratio] in Urine

15298

90512

1.14

35.60

4.2

4.0

10.9

8.9

mg/mmol

4.71

9524

57576

(3020891) Body temperature

2296

11287

1.34

35.08

5.2

4.9

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2633

13207

1.31

34.95

3.5

2.9

1.3

0.56

2623

13138

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2579

12916

1.31

34.61

3.5

2.9

0.7

0.11

2483

12388

(3017732) Neutrophils [#/volume] in Blood

3883

20516

1.25

33.99

3.0

2.8

4.0

4.1

e9/l

3.54

2938

16037

(3049717) Cytology report of Urine Cyto stain

2223

10954

1.33

33.42

2.5

2.7

—

(44806071)

153

318

3.14

33.41

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1360

6178

1.44

33.33

1.5

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

409

1372

1.95

32.31

1.1

3.6

4.1

iu/ml

0.43

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

836

3450

1.59

32.25

2.4

2.1

32.5

32.7

0.83

828

3426

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1275

5759

1.45

32.21

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

661

2577

1.68

31.96

3.0

2.8

—

(3009508) Creatinine [Moles/volume] in Urine

15374

91493

1.13

31.78

3.4

3.2

7.2

7.8

mmol/l

50.21

12856

77083

(4281824)

730

2926

1.63

31.73

1.2

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

748

3017

1.62

31.71

4.1

3.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

13108

77268

1.14

31.51

1.7

1.6

1.4

mmol/l

2.60

11000

65184

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6406

35816

1.19

31.47

8.2

6.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

301

910

2.16

31.37

1.2

0.2

0.6

g/l

1.18

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1260

5710

1.45

31.29

1.5

1.4

17.5

19.1

u/ml

0.20

107

(3004119) Hemoglobin [Mass/volume] in Venous blood

3283

17217

1.26

30.60

4.0

3.3

127.8

129.4

g/l

3.65

3202

16833

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

777

3192

1.59

30.58

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

472

1693

1.82

30.48

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

478

1725

1.81

30.27

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

1774

8584

1.36

30.08

4.6

4.5

3.9

mmol/l

1.03

1652

8082

(3014271) Vancomycin [Susceptibility]

388

1315

1.93

29.81

3.4

2.8

—

(3042631) Mycobacterium sp identified in Specimen

895

3825

1.53

29.67

2.5

2.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1163

5249

1.45

29.53

1.7

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2966

15448

1.26

29.29

3.1

2.7

0.3

e6/l

0.01

2886

15016

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

866

3685

1.54

29.28

1.5

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

833

3522

1.55

28.99

1.6

1.5

57.5

57.9

0.08

527

2237

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

968

4233

1.50

28.82

1.5

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1019

4515

1.48

28.45

1.6

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1103

4964

1.46

28.44

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

845

3603

1.53

28.33

1.5

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

860

3687

1.53

28.13

1.5

1.4

—

(3044927) Protein electrophoresis panel - Urine

652

2625

1.62

27.92

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

842

3600

1.53

27.89

1.5

1.4

—

(4010399)

3910

21103

1.22

27.89

1.5

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3714

29083

0.82

27.62

1.7

—

(3042733) HLA Ab [Presence] in Serum

303

967

2.05

27.57

3.9

5.3

—

(3045142) Bone marrow Pathology biopsy report

717

2964

1.58

27.55

1.4

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

556

2157

1.68

27.47

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

3463

18485

1.23

27.46

1.3

198.9

246.8

u/ml

2.36

3195

17170

(3003434) Protein [Mass/volume] in Pleural fluid

842

3616

1.52

27.34

1.5

1.4

32.2

33.2

g/l

1.24

767

3249

(3024928) Oxygen saturation in Venous blood

1267

5903

1.41

27.06

3.7

3.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

830

3566

1.52

26.90

1.5

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1198

5534

1.42

26.86

1.3

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

829

3563

1.52

26.83

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

501

5365

0.60

26.56

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2855

14974

1.25

26.53

3.7

3.2

57.3

48.8

u/ml

0.56

2765

14455

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

506

5403

0.61

26.51

1.5

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

539

5666

0.62

26.44

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

506

5399

0.61

26.43

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

826

3562

1.52

26.33

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

505

5385

0.61

26.31

1.5

1.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

518

1995

1.70

26.31

1.4

12.5

12.3

umol/l

0.26

498

1891

(3042111) Morphology [Interpretation] in Bone marrow Narrative

996

4464

1.46

26.28

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1130

5208

1.42

25.68

1.3

294.3

269.5

u/ml

2.03

750

3405

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1140

5264

1.42

25.64

1.6

1.5

114.7

112.5

u/ml

0.15

247

1210

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

544

2139

1.66

25.59

1.1

292.2

429.6

mg/l

0.49

486

1920

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

189

511

2.41

25.57

1.3

1.2

41.9

43.6

mg/l

0.02

136

371

(3050129) First trimester maternal screen panel - Serum or Plasma

664

6601

0.65

25.30

1.5

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1028

4685

1.44

24.86

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3450

18602

1.22

24.78

3.2

3.4

4.4

4.5

pmol/l

3.70

3058

16612

(3045414) Leukocytes [Presence] in Urine

2467

12838

1.26

24.51

1.9

1.8

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

825

3614

1.49

24.44

1.3

1.2

55.0

54.6

u/ml

0.01

245

(3016650) Hepatitis A virus Ab [Presence] in Serum

1026

4690

1.43

24.42

1.1

—

(3047181) Lactate [Moles/volume] in Blood

1794

8967

1.31

24.42

6.1

5.8

1.3

mmol/l

2.49

1589

7919

(3048929) Epstein Barr virus Ab [Presence] in Serum

1657

8190

1.33

24.42

1.3

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

884

3931

1.47

24.32

1.5

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1271

6035

1.38

24.31

1.3

1.2

40.0

44.1

u/ml

0.42

155

574

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

473

1817

1.70

24.30

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

474

1826

1.70

24.11

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

2244

11570

1.27

24.07

5.5

5.0

0.9

0.04

2104

10862

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2281

11786

1.27

24.05

5.5

4.9

1.7

0.41

2135

11076

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3826

20904

1.21

23.99

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

404

4444

0.59

23.92

1.5

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2622

13780

1.25

23.92

4.2

3.3

25.2

mmol/l

0.29

2555

13359

(36660697) Celiac disease serology panel - Serum

4109

22612

1.20

23.84

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

419

4561

0.60

23.80

1.5

—

(44806118)

714

3062

1.52

23.41

1.6

1.5

—

(3005033) Fetal Nuchal fold Thickness US

406

4435

0.59

23.40

1.5

1.4

—

(44790049)

714

3063

1.52

23.38

1.6

1.5

—

(44790048)

714

3064

1.52

23.35

1.6

1.5

—

(44790047)

714

3064

1.52

23.35

1.6

1.5

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

100

201

3.24

23.19

3.3

1.8

59.2

59.0

0.02

124

(3017354) Segmented neutrophils/100 leukocytes in Blood

661

2795

1.55

23.12

3.7

3.2

59.0

58.4

0.22

454

1767

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

360

1300

1.81

22.91

1.5

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1023

4731

1.41

22.86

1.7

1.5

0.8

g/l

0.04

758

3573

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

360

1301

1.81

22.85

1.5

1.4

—

(3024932) HLA-DR beta [Type]

283

945

1.95

22.85

1.1

—

(3024471) HLA-A [Type]

288

970

1.94

22.69

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

636

2678

1.55

22.67

1.2

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1466

7207

1.33

22.45

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

715

3097

1.51

22.41

1.5

39.8

31.3

iu/ml

0.56

144

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1135

5370

1.38

22.23

3.7

3.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

686

2953

1.52

22.14

1.8

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2674

14216

1.24

21.97

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

684

2948

1.52

21.96

3.7

3.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

640

2723

1.54

21.80

1.8

1.7

—

(3003181) Sodium [Moles/volume] in Urine

1008

4694

1.41

21.69

1.4

63.7

62.5

mmol/l

0.39

794

3690

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2415

12738

1.24

21.33

4.7

3.9

48.9

48.3

0.56

2390

12598

(3002385) Erythrocyte distribution width [Ratio]

39456

249271

1.10

21.30

22.7

16.1

13.9

13.7

96.09

38734

244026

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1582

7931

1.31

21.11

2.2

2.1

11.4

10.9

mg/l

1.67

1469

7427

(3022621) pH of Urine by Test strip

3423

18732

1.20

21.05

3.1

2.8

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

982

4579

1.40

20.98

1.3

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

620

2644

1.53

20.93

1.5

1.4

119081.3

103632.3

e6/l

0.21

417

1838

(3012441) Differential panel - Pleural fluid

649

2802

1.51

20.70

1.6

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

493

2004

1.61

20.47

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2444

19355

0.81

20.18

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

732

3259

1.47

20.11

1.6

1.5

3053.4

3239.4

e6/l

0.05

531

2372

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

477

1936

1.61

19.95

1.6

1.5

28.7

24.2

u/ml

0.82

400

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

567

2399

1.54

19.86

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

567

2399

1.54

19.86

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

567

2399

1.54

19.86

1.7

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

315

1145

1.80

19.71

2.6

2.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

612

2649

1.51

19.33

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

186

566

2.14

19.32

2.6

2.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

415

4303

0.63

19.32

1.8

1.7

—

(3045788) Cell count panel - Pleural fluid

579

2477

1.53

19.31

1.6

1.5

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

533

2242

1.55

19.18

1.2

1.1

47.9

51.8

u/ml

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1635

8350

1.28

18.99

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

647

2847

1.48

18.89

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3674

20428

1.18

18.86

2.4

24.9

24.0

au/ml

0.15

198

1228

(3014765) Yersinia sp identified in Stool by Organism specific culture

1647

8435

1.28

18.71

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

266

934

1.86

18.62

1.8

1.6

13788.3

30974.8

u/ml

0.49

121

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

574

2474

1.52

18.52

1.4

1.3

502.5

487.1

u/l

0.06

543

2341

(42529406) Shigella sp [Presence] in Stool by Culture

1647

8450

1.28

18.45

1.2

—

(40768806) Pleura Pathology biopsy report

639

2823

1.48

18.31

1.6

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

775

3554

1.43

18.27

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

712

3216

1.45

18.21

7.1

8.9

7.3

7.4

mmol/l

0.10

591

2633

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

160

3.22

18.21

3.4

1.7

15.6

16.1

0.04

(3036782) Glucose [Moles/volume] in Pleural fluid

585

2545

1.50

18.08

1.4

1.3

6.2

6.3

mmol/l

0.55

547

2345

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

778

3578

1.42

18.06

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

389

1542

1.65

17.93

1.6

1.5

—

(3051651) Icteric interference index of Serum or Plasma

416

1682

1.61

17.74

4.0

3.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3359

18631

1.18

17.73

1.3

41.3

51.1

au/ml

1.57

131

797

(21494890) Protein electrophoresis panel - 24 hour Urine

646

2879

1.47

17.73

2.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

386

1534

1.64

17.63

1.6

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

659

2953

1.46

17.59

1.6

1.4

62715.2

55955.4

e6/l

0.24

391

1782

(3011412) CD3 cells [#/volume] in Blood

623

2764

1.47

17.50

2.3

2.4

1.1

1.2

e9/l

1.95

385

1644

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

366

1438

1.66

17.48

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

366

1438

1.66

17.48

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

366

1438

1.66

17.48

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

366

1438

1.66

17.48

1.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1672

8656

1.27

17.41

1.4

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

668

3012

1.45

17.28

2.4

—

(21494434) Karyotype in Bone marrow

541

2340

1.51

17.21

1.1

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

932

4460

1.37

17.14

1.3

46.3

31.8

u/l

1.37

810

3883

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

412

1677

1.60

17.12

1.3

503.3

382.6

titre

0.31

119

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

613

2726

1.47

17.04

1.6

1.5

30.2

30.1

0.04

381

1712

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

6906

40488

1.13

16.79

1.7

1.6

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

401

1630

1.61

16.77

1.3

62.6

80.2

titre

0.46

135

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

480

2038

1.54

16.66

1.8

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

473

2007

1.54

16.47

2.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

751

3492

1.41

16.43

2.4

2.0

27.5

27.0

mg/l

0.08

215

924

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

684

3128

1.43

16.43

1.2

65.7

61.1

u/l

0.28

470

2097

(3023419) Bacteria identified in Sputum by Culture

757

3531

1.40

16.27

2.6

2.4

—

(3019230) Fractional oxyhemoglobin in Venous blood

989

4818

1.34

16.24

3.9

3.1

63.3

65.1

1.63

982

4797

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

424

1761

1.57

16.23

1.5

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

505

2182

1.51

16.18

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1702

8909

1.25

16.15

1.6

2.6

7.1

iu/ml

0.81

392

1868

(40759836) Histone Ab [Presence] in Serum by Immunoblot

504

2178

1.51

16.14

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

504

2181

1.51

16.04

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

589

2632

1.46

16.01

3.7

3.8

43.6

50.1

u/ml

0.51

583

2605

(4062490)

662

3026

1.43

15.96

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

542

2385

1.48

15.92

2.0

1.9

0.9

1.1

g/24h

0.23

135

(3027135) IgG subclass 1 [Mass/volume] in Serum

660

3024

1.43

15.72

1.4

7.0

6.8

g/l

0.44

443

2120

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

506

2202

1.50

15.69

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

506

2203

1.50

15.66

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

457

1949

1.53

15.58

1.3

12.9

14.2

u/l

0.53

412

1808

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

506

2206

1.50

15.56

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

658

3020

1.42

15.53

1.4

0.4

g/l

0.15

445

2120

(3028192) IgG subclass 2 [Mass/volume] in Serum

658

3021

1.42

15.50

1.4

3.0

g/l

0.07

444

2113

(3027944) Amphetamines [Presence] in Urine

1237

10256

0.78

15.45

2.5

1.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

430

1813

1.55

15.44

1.2

—

(3039000) Anion gap in Blood

1254

6361

1.29

15.43

7.2

6.7

11.1

11.2

mmol/l

0.77

1131

5741

(3018572) Chloride [Moles/volume] in Blood

1254

6362

1.29

15.42

7.2

6.7

105.0

105.1

mmol/l

0.26

1131

5743

(3013139) Helicobacter pylori Ag [Presence] in Stool

3488

19637

1.17

15.33

1.2

—

(3027008) Opiates [Presence] in Urine

1262

10426

0.78

15.31

2.5

2.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

510

2236

1.49

15.28

1.2

73.5

68.3

u/ml

0.12

101

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

510

2243

1.48

15.05

1.2

58.5

41.7

u/ml

0.87

162

(3038026) Centromere Ab [Units/volume] in Serum

520

2296

1.48

15.05

1.3

1.2

58.5

52.2

u/ml

0.13

(3019832) Treponema pallidum Ab [Presence] in Serum

3065

23169

0.85

15.00

1.6

—

(3028300) Cannabinoids [Presence] in Urine

1270

10450

0.79

14.90

2.7

2.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1473

7664

1.26

14.77

1.2

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

1261

10363

0.79

14.65

2.6

2.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

495

2177

1.48

14.63

2.1

1.8

3.8

mg/l

0.06

471

2071

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

535

2390

1.46

14.62

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

931

4572

1.33

14.54

3.9

3.5

37.2

37.4

u/ml

0.01

895

4407

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

593

2706

1.43

14.49

3.8

3.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

198

690

1.87

14.33

1.3

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

289

1127

1.67

14.31

2.1

2.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

336

3404

0.64

14.24

1.4

—

(3016879) Cocaine [Presence] in Urine

1170

9664

0.78

14.20

2.7

2.0

—

(3026470) Cobalt [Mass/volume] in Blood

392

1651

1.55

14.20

2.0

4.1

3.4

ug/l

0.62

344

1456

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

286

1115

1.67

14.18

2.1

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

286

1116

1.67

14.14

2.1

2.0

—

(3000492) Spirometry study

5008

29081

1.13

14.13

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

458

2002

1.49

13.97

1.6

1.4

13.6

12.6

u/l

1.92

437

1938

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

486

2151

1.47

13.95

1.2

9.7

9.3

u/ml

0.02

142

(3013727) Leukocytes other/100 leukocytes in Blood

240

896

1.75

13.92

3.7

3.6

54.2

52.8

0.46

232

864

(3036670) Protein [Mass/volume] in Synovial fluid

217

792

1.79

13.59

1.3

1.2

40.6

39.8

g/l

0.36

114

430

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

408

1756

1.52

13.43

1.3

1.2

98.6

92.0

u/l

0.63

358

1537

(1175426) CD3 cells/100 lymphocytes in Blood

488

2181

1.46

13.36

2.2

2.0

72.5

72.7

0.11

470

2091

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

322

1315

1.60

13.34

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

30482

192122

1.07

13.33

3.0

2.9

—

(3035880) pH of Pleural fluid

352

1469

1.56

13.31

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

322

1316

1.60

13.30

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

376

1596

1.54

13.20

1.8

2.0

2.4

u/field

0.60

288

1129

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

480

2144

1.46

13.18

2.1

2.0

15.4

14.3

0.88

222

980

(21494815) CD4 cells/100 lymphocytes in Specimen

545

2494

1.43

13.17

2.2

2.1

39.3

40.3

0.15

334

(4024509)

547

2506

1.42

13.13

1.6

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

169

578

1.91

13.00

6.6

5.7

69.6

70.5

0.17

137

457

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

374

1593

1.53

12.93

2.6

2.4

957.5

1115.7

u/ml

0.56

368

1571

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

424

1859

1.49

12.80

2.1

1.8

—

(3025577) Chromium [Mass/volume] in Blood

376

1609

1.52

12.74

2.0

2.1

2.5

2.2

ug/l

0.61

304

1359

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3982

29209

0.88

12.72

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

198

2211

0.58

12.72

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2078

11397

1.19

12.52

1.1

16.4

7.0

u/ml

0.40

160

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

456

2038

1.46

12.52

1.3

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

394

1710

1.50

12.51

1.3

1.2

26.8

25.0

u/l

0.29

341

1470

(3045424) Erythrocytes [Presence] in Urine

970

4896

1.29

12.50

1.5

1.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

247

2.40

12.49

1.2

—

(3017704) Immunofixation for Urine

353

1498

1.54

12.44

1.7

1.6

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

201

2.56

12.39

1.2

90.3

107.8

ug/l

0.45

127

(1001926) Buprenorphine [Presence] in Urine by Screen method

961

7978

0.78

12.22

2.9

2.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

248

973

1.66

12.10

2.0

2.1

67.7

55.6

ug/l

1.24

240

954

(43055442) Apixaban [Mass/volume] in Serum or Plasma

109

327

2.17

11.95

1.7

1.5

102.9

113.8

ug/l

0.44

267

(40768446) Kidney Pathology biopsy report

283

1153

1.60

11.91

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1996

10962

1.19

11.86

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

215

819

1.71

11.71

1.1

—

(3010503) CD19 cells [#/volume] in Blood

394

1738

1.48

11.60

2.4

2.6

0.4

0.3

e9/l

0.04

377

1695

(3034891) Synovial lining cells/100 cells in Synovial fluid

328

1393

1.54

11.56

1.5

2.9

4.2

1.24

321

(3000012) Reticulocyte production index

352

1521

1.51

11.46

1.6

1.5

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

676

3286

1.34

11.43

3.2

3.3

8.7

7.2

nmol/l

0.22

651

3194

(40762365) Oxygen content in Arterial blood by calculation

136

452

1.96

11.43

2.9

3.0

14.8

ml/dl

0.07

129

421

(3044242) Glucose [Moles/volume] in Arterial blood

307

1289

1.55

11.39

2.2

1.9

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

548

2578

1.39

11.39

2.3

2.5

0.9

0.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

291

1208

1.57

11.35

3.1

5.3

2839.9

2015.9

mg/l

0.24

209

869

(3014051) Protein [Presence] in Urine by Test strip

1201

6299

1.25

11.34

2.3

2.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

317

1347

1.53

11.17

3.4

3.3

—

(4015189)

193

724

1.74

11.13

2.3

2.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1127

5882

1.25

11.12

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

233

925

1.64

10.92

1.2

1.1

104.5

108.3

0.72

206

842

(3019977) pH of Arterial blood

357

1565

1.49

10.88

2.7

2.5

7.4

0.08

130

538

(3008295) Osmolality of Serum or Plasma

568

2715

1.37

10.74

1.5

1.4

279.9

279.0

mosm/kgh2o

0.40

440

2118

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

225

893

1.64

10.58

1.2

1.1

87.0

90.2

0.55

123

407

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

290

1224

1.55

10.56

1.8

131.2

127.3

umol/l

0.06

132

638

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

500

2350

1.39

10.49

1.9

2.0

1.9

2.3

u/field

0.74

253

986

(3052592) Norovirus Ag [Presence] in Stool

153

546

1.83

10.44

1.4

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

701

5931

0.77

10.43

1.7

1.6

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

314

1354

1.51

10.38

1.6

1.4

21.6

26.4

umol/l

2.17

305

1275

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1537

8351

1.20

10.33

1.4

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

228

915

1.62

10.28

1.1

86.6

89.3

0.55

121

415

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

419

1917

1.43

10.27

2.5

2.6

0.2

e9/l

0.39

361

1670

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

703

3499

1.31

10.16

1.9

21.4

25.6

ug/l

1.49

689

3429

(1761868) Lipid panel - Serum or Plasma

16373

111564

0.94

10.14

2.9

2.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

560

4860

0.75

10.06

1.5

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

152

2.61

10.04

1.1

1.0

1.3

u/field

1.69

102

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

7616

45998

1.09

10.00

1.4

1.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

302

1303

1.51

9.98

1.9

1.7

161.6

142.5

3.28

275

1230

(3051593) INR in Capillary blood by Coagulation assay

303

1310

1.51

9.92

9.9

10.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

197

770

1.67

9.86

1.4

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

429

1990

1.41

9.76

2.4

2.6

509.5

518.2

e6/l

0.13

358

1678

(3042010) Triglyceride [Moles/volume] in Pleural fluid

112

369

1.98

9.73

1.3

1.2

1.1

1.3

mmol/l

0.22

236

(3000330) Specific gravity of Urine by Test strip

2506

14250

1.15

9.69

3.9

3.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

117

395

1.93

9.50

1.1

—

(40768795) Lymph node Pathology biopsy report

580

2839

1.33

9.46

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

916

4763

1.26

9.42

1.2

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

116

2.81

9.41

1.5

1.4

186.3

182.6

ug/g

0.05

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

474

2251

1.37

9.41

1.3

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1420

7730

1.20

9.39

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3622

26240

0.89

9.39

1.9

1.8

—

(3023383) Lactate [Moles/volume] in Pleural fluid

203

811

1.63

9.37

1.4

1.3

3.5

3.6

mmol/l

0.09

181

745

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

151

2.55

9.26

1.2

1.4

66.7

1409.9

u/l

1.55

130

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

161

607

1.73

9.22

1.4

1.2

106.4

109.1

0.38

149

578

(3024263) Appearance of Synovial fluid

334

1499

1.45

9.14

1.6

1.7

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

302

2.05

9.12

1.4

63.3

74.2

2.23

256

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

445

2108

1.38

8.99

1.3

1.1

1.3

u/ml

0.19

213

947

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

304

1345

1.47

8.96

3.7

3.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2125

15875

0.87

8.93

1.9

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3397

19817

1.12

8.87

1.2

138.9

142.8

iu/ml

0.22

1231

7594

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

128

2.65

8.81

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

592

2942

1.31

8.73

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

148

2.51

8.72

2.7

1.8

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

199

807

1.61

8.69

1.4

2.7

2.6

0.05

161

684

(3016244) Insulin [Units/volume] in Serum or Plasma

361

1668

1.41

8.48

3.6

3.3

29.3

27.8

mu/l

0.25

344

1574

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

110

379

1.89

8.47

1.1

—

(3004451) EKG impression Narrative

302

1351

1.46

8.45

1.3

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

161

623

1.68

8.45

1.5

0.4

ug/l

0.15

101

412

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

410

1939

1.38

8.41

1.3

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1157

6254

1.21

8.31

3.9

3.3

26.5

27.0

mg/l

0.18

744

3933

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

3.42

8.27

1.1

1.0

1.2

1.5

u/field

0.55

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

214

896

1.56

8.21

1.9

2.0

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

261

1143

1.49

8.14

2.4

1.6

1.9

2.0

umol/l

0.58

249

1068

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

331

3005

0.72

8.09

1.7

1.4

3.4

3.6

ug/l

0.10

250

2549

(40762814) Titanium [Mass/volume] in Blood

124

451

1.79

8.09

2.2

2.3

3.4

3.8

ug/l

0.37

150

(3003327) Ova and parasites identified in Stool by Light microscopy

1745

9807

1.16

7.98

1.7

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1212

6613

1.20

7.90

1.4

147.9

127.6

pmol/l

0.53

1187

6455

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

438

2117

1.35

7.87

2.4

2.6

669.4

666.2

e6/l

0.03

176

866

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

233

2.10

7.71

1.1

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

122

449

1.77

7.68

1.4

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

273

1225

1.45

7.58

1.5

1.6

3146627.0

1985625.0

iu/ml

0.43

(3032057) Clostridioides difficile [Presence] in Stool

149

583

1.67

7.56

2.0

1.8

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

320

1.91

7.55

1.4

1.2

835.9

79.0

u/l

0.76

236

(3001186) Copper [Moles/volume] in Serum or Plasma

169

685

1.61

7.48

1.4

1.2

16.9

17.0

umol/l

0.05

155

607

(3005082) Progesterone [Moles/volume] in Serum or Plasma

101

1161

0.57

7.48

1.3

1.4

25.8

30.3

nmol/l

1.13

1033

(3009015) Lactate [Moles/volume] in Synovial fluid

267

2.00

7.47

1.3

1.2

6.1

6.4

mmol/l

0.13

135

(3037692) Legionella sp identified in Specimen by Organism specific culture

229

996

1.50

7.43

1.4

1.5

—

(3016228) CD19 cells/100 cells in Blood

257

1145

1.46

7.41

2.1

2.0

7.8

8.6

0.45

249

1116

(3047189) Immunofixation for 24 hour Urine

277

1253

1.44

7.38

1.7

1.8

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

199

1944

0.67

7.36

19.2

18.0

1348.5

3108.9

nmol/l

1.10

189

1857

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

294

1346

1.42

7.35

1.2

—

(4034850)

1712

9673

1.16

7.33

10.7

9.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

251

1118

1.46

7.26

2.1

2.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

117

433

1.76

7.26

2.5

2.9

1979.0

1708.7

u/l

0.10

105

386

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

226

2.08

7.24

1.4

1.3

1.5

ml/s/173m2

0.18

145

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

134

516

1.69

7.23

2.8

2.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

424

2069

1.34

7.20

2.9

2.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

285

1.94

7.16

2.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2530

14699

1.13

7.14

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

280

1278

1.43

7.13

2.4

2.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

382

1838

1.36

7.12

1.7

1.6

7.1

6.1

u/l

0.39

201

879

(3027923) C peptide [Moles/volume] in Serum or Plasma

335

1582

1.38

7.03

1.5

1.3

1.2

nmol/l

0.43

250

1253

(3011544) Albumin [Mass/volume] in Pleural fluid

238

2.03

7.00

1.1

16.8

17.7

g/l

0.42

212

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

219

957

1.49

6.98

1.5

1.4

65.2

61.6

0.80

173

790

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

189

1840

0.67

6.90

13.5

12.9

810.2

1379.0

nmol/l

0.53

181

1776

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

289

1.92

6.90

3.2

2.9

1.3

mg/l

0.01

204

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

326

1.86

6.89

1.2

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

187

793

1.54

6.87

1.6

9.2

9.1

ug/l

0.13

187

793

(3016038) Potassium [Moles/volume] in Urine

368

1773

1.35

6.83

1.2

34.1

34.4

mmol/l

0.09

324

1504

(3035637) Corticotropin [Mass/volume] in Plasma

689

3608

1.25

6.81

1.4

1.6

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

349

1670

1.36

6.77

2.8

2.9

25.3

26.1

ug/l

—

(3009542) Hematocrit [Volume Fraction] of Blood

42956

275799

1.06

6.77

19.8

14.3

39.4

40.0

35.01

30141

203138

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

107

2.56

6.76

1.1

1.0

0.1

u/ml

0.04

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

219

965

1.48

6.73

2.0

1.8

195.7

164.7

3.10

207

909

(3036048) Francisella tularensis Ab [Titer] in Serum

158

648

1.59

6.71

1.2

120.0

628.2

titre

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

253

1149

1.44

6.66

2.4

1.6

27.6

29.8

umol/l

2.58

243

1104

(40768793) Breast Pathology biopsy report

1154

6386

1.18

6.49

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

347

1672

1.35

6.46

2.6

2.8

39.2

38.9

0.09

124

552

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

145

589

1.60

6.43

1.4

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2338

13614

1.12

6.39

1.1

127.3

219.5

titre

1.72

342

(3045716) Anion gap in Serum or Plasma

274

1274

1.40

6.35

2.8

2.3

9.0

9.1

mmol/l

0.31

190

940

(3001686) Cold agglutinin [Titer] in Serum or Plasma

125

491

1.66

6.33

1.2

1.4

46.3

174.0

titre

—

(3048879) Bone marrow aspiration report

185

798

1.51

6.33

1.9

1.8

—

(3025315) Body weight

239

1.96

6.29

5.2

4.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

171

726

1.53

6.29

1.4

23.4

22.1

0.22

149

662

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

145

593

1.59

6.27

1.3

1.1

87.1

88.8

0.14

168

(3006245) CD3-CD19+ cells/100 cells in Blood

238

1082

1.43

6.26

2.4

2.1

9.7

10.3

0.28

220

1004

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

356

1733

1.34

6.22

1.5

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

230

1041

1.44

6.20

1.2

0.3

g/l

0.22

191

821

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

120

2.39

6.20

1.1

1.0

0.2

0.1

u/ml

0.21

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

177

761

1.52

6.16

2.0

26.7

41.2

u/l

1.08

163

680

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

394

1953

1.32

6.09

3.3

3.4

160.5

127.7

nmol/l

0.78

385

1924

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

8331

51383

1.06

6.05

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

783

4212

1.21

6.05

1.4

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

232

1057

1.43

6.05

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

582

3035

1.25

6.03

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

189

831

1.48

5.93

1.5

1.6

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

233

1067

1.42

5.92

2.2

2.1

29.0

29.4

0.18

223

1006

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

11741

79753

0.95

5.91

4.4

4.1

22.0

0.05

5689

37720

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

110

426

1.68

5.91

5.4

5.1

58.0

44.3

ug/min

1.19

336

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

138

568

1.58

5.85

1.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

143

594

1.57

5.83

1.2

1.1

76.6

76.0

0.04

162

(3028433) Virus identified in Specimen by Culture

209

941

1.45

5.82

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

238

1098

1.41

5.81

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

313

1.79

5.74

2.1

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1697

12472

0.88

5.71

1.8

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1307

7387

1.16

5.68

1.3

583.4

541.7

mg/l

0.55

1253

7040

(3041918) Cholesterol [Moles/volume] in Pleural fluid

121

489

1.61

5.55

1.3

1.2

1.6

1.7

mmol/l

0.06

306

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

170

745

1.49

5.46

1.3

366.3

228.3

ug/l

0.30

406

(3012565) Volume of 24 hour Urine

308

1499

1.34

5.46

2.2

1994.1

1991.7

0.01

274

1340

(46235355) HIV 1 and 2 tests - Meaningful Use set

7875

48638

1.06

5.45

1.8

—

(3010838) Calcium [Moles/time] in 24 hour Urine

292

1410

1.35

5.45

1.7

1.6

5.1

5.7

mmol/24h

0.32

110

(3013166) Neutrophils/100 leukocytes in Synovial fluid

194

876

1.44

5.37

1.5

1.3

58.2

54.6

0.67

168

749

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

225

1045

1.40

5.33

1.3

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

237

1111

1.39

5.32

2.8

2.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

407

2068

1.28

5.30

1.7

1.5

67.8

70.1

umol/l

0.40

162

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

531

2790

1.24

5.22

1.4

1.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1439

10611

0.88

5.15

1.9

1.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

142

1373

0.67

5.14

1.5

1.4

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

209

966

1.41

5.11

1.2

114.0

111.3

0.78

190

860

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1427

8180

1.14

5.11

1.1

4.8

5.8

u/ml

0.47

153

1075

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.66

5.11

1.1

1.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

311

1534

1.32

5.07

1.2

1.1

23.7

25.5

u/l

0.27

232

1188

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

169

755

1.46

4.98

1.2

1.3

127.7

128.9

nmol/l

0.03

119

560

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

107

433

1.61

4.93

1.7

1.6

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

3.05

4.89

1.2

1.4

0.8

0.6

u/field

0.62

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3958

27665

0.93

4.85

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

133

569

1.52

4.84

1.1

0.7

0.8

umol/24h

0.59

290

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

309

1535

1.31

4.81

1.2

1.1

90.3

85.8

u/l

0.41

240

1236

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

115

477

1.57

4.80

2.8

2.5

87.7

49.1

mg/l

0.40

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1148

6515

1.15

4.79

1.4

30.8

32.3

e6/l

0.06

896

5021

(3019420) Tryptase [Mass/volume] in Serum or Plasma

310

1542

1.31

4.79

1.5

8.1

ug/l

0.00

286

1393

(3018851) Theophylline [Moles/volume] in Serum or Plasma

240

1.82

4.78

2.0

1.7

46.8

46.5

umol/l

0.02

240

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1148

6517

1.15

4.77

1.3

3.7

3.8

mmol/l

1.65

1076

6118

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

269

1.77

4.75

1.1

19.4

20.5

u/l

0.15

176

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

348

1.67

4.71

8.2

7.8

0.4

umol/l

0.11

316

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

160

716

1.46

4.70

1.4

1.3

35.7

38.5

0.39

100

487

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

218

1.85

4.69

1.1

28.0

14.5

iu/ml

0.60

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

769

4239

1.18

4.67

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1147

6523

1.15

4.66

1.4

1867.1

2266.1

e6/l

0.20

947

5290

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

150

666

1.47

4.60

1.2

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

322

1621

1.29

4.57

1.3

1.2

252.0

326.7

u/l

0.86

302

1514

(40763480) Human metapneumovirus Ag [Presence] in Specimen

121

2.15

4.55

1.2

1.4

—

(3002619) Bacteria identified in Specimen by Culture

133

578

1.50

4.53

1.4

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

116

490

1.54

4.50

4.7

5.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

643

3503

1.20

4.48

2.8

2.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

130

564

1.50

4.47

2.4

2.1

—

(3006270) Folate [Moles/volume] in Blood

472

2495

1.23

4.46

1.2

344.1

368.5

nmol/l

1.55

394

2095

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

101

2.26

4.45

1.1

1.0

1.3

u/field

0.52

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

506

2698

1.22

4.41

4.3

4.8

79.2

104.2

u/ml

0.54

144

835

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

146

651

1.46

4.40

1.5

1.4

24.2

22.4

0.30

114

547

(3044290) Cell count panel - Cerebral spinal fluid

1079

6141

1.15

4.36

1.3

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

186

870

1.39

4.33

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

186

870

1.39

4.33

2.5

—

(3011288) Drugs identified in Urine by Screen method

903

6783

0.86

4.32

4.3

2.9

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

234

1.78

4.31

1.1

1.2

39.0

48.9

mg/l

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

182

851

1.39

4.25

1.2

—

(3042301) Urate [Moles/volume] in Synovial fluid

2.85

4.21

1.0

325.2

357.2

umol/l

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

430

2269

1.24

4.17

1.2

1.3

2.2

2.1

mmol/l

0.28

404

2097

(3029634) Reagin Ab [Titer] in Serum by VDRL

721

3998

1.18

4.14

2.1

2.2

1.9

7.7

titre

2.75

121

(40757494) Bilirubin.total [Moles/volume] in Blood

306

1555

1.28

4.10

2.0

2.2

17.6

27.8

umol/l

1.42

147

(3049242) von Willebrand panel - Platelet poor plasma

2.36

4.09

1.6

1.7

—

(40757373) Influenza virus identified in Isolate

126

555

1.48

4.07

1.5

1.7

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

603

3299

1.19

4.06

1.1

1.8

2.0

iu/ml

0.21

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

343

1.61

4.04

1.5

1.4

8.9

71.9

u/ml

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

239

1177

1.32

4.04

1.1

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

101

425

1.55

4.04

2.9

3.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

274

1377

1.30

4.00

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

1103

6328

1.14

4.00

3.8

3.1

1.6

mmol/l

0.39

1080

6204

(3018834) Bilirubin.total [Presence] in Urine by Test strip

133

2.01

3.96

4.0

3.4

0.0

estimate

—

(44786800) Granulocytes/100 leukocytes in Body fluid

336

1.61

3.91

1.3

27.9

23.4

0.52

262

(3006969) Lambda light chains [Mass/volume] in Urine

2.58

3.89

1.0

1.1

0.1

0.0

g/l

0.58

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

404

1.55

3.85

1.3

1.4

78577.2

234803.2

nmol/l

0.77

342

(40765096) Chromosome analysis panel by Banding

168

791

1.38

3.82

1.1

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.48

3.77

1.0

1.1

0.6

0.0

g/l

—

(3008898) HLA-B27 [Presence]

1696

10013

1.11

3.77

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

370

1946

1.24

3.75

1.3

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

172

817

1.37

3.72

1.4

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

403

1.54

3.70

1.5

1.4

8.8

12.5

0.92

202

(3000060) B lymphocytes [#/volume] in Blood

166

789

1.37

3.59

2.4

2.0

123.2

943.2

e6/l

1.65

431

(3009871) Measles virus Ab [Titer] in Serum

214

1058

1.32

3.57

1.7

1.6

—

(3006576) Bicarbonate [Moles/volume] in Blood

209

1030

1.32

3.57

5.4

6.4

24.9

25.1

mmol/l

0.28

187

936

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

186

901

1.34

3.57

2.8

3.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

249

1.67

3.55

1.1

—

(3016750) Collection duration of Urine

330

1727

1.25

3.52

2.3

2.2

491.3

501.1

min

0.91

246

1275

(3043410) Blood group antigens tested for on Red Blood Cells

161

765

1.37

3.50

1.7

1.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

365

1933

1.23

3.50

1.3

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

123

558

1.44

3.48

1.5

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1357

9786

0.90

3.45

1.6

1.7

303.9

305.9

mu/l

0.06

1233

8873

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

169

1.81

3.42

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

174

1.80

3.40

1.2

1.4

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.08

3.33

1.1

1.2

5381.8

2398.2

ng/l

0.58

(3003129) Base excess in Capillary blood by calculation

151

719

1.37

3.27

1.6

1.7

0.3

0.6

mmol/l

0.44

140

679

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

305

1598

1.24

3.26

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

215

1080

1.30

3.24

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

258

1327

1.27

3.23

1.1

4.5

8.2

u/ml

2.19

232

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

103

460

1.46

3.20

1.2

1.1

2.4

8.2

pmol/l

0.72

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

277

1439

1.25

3.20

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

339

1801

1.23

3.19

5.8

6.5

—

(3038515) Glucose [Moles/volume] in Venous blood

1031

5985

1.12

3.19

4.0

3.2

7.4

7.6

mmol/l

1.11

1008

5884

(3020393) Adenovirus Ag [Presence] in Stool

284

1.58

3.12

1.3

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

278

1451

1.25

3.10

1.3

1.2

56.8

61.3

0.34

152

(3013293) Extractable nuclear Ab [Presence] in Serum

433

1.46

3.04

1.7

1.5

—

(3036603) Volume of Urine

374

2021

1.21

3.00

1.6

1845.2

1954.6

0.56

474

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

104

472

1.44

3.00

1.2

1.3

958.0

104.2

ng/l

0.51

314

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

184

917

1.31

2.98

1.4

1.2

26.7

21.3

0.40

145

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

483

2673

1.18

2.97

1.4

1.3

1.5

1.4

nmol/l

1.02

436

2417

(3002621) Streptococcal DNAse B [Units/volume] in Serum

232

1.63

2.96

1.1

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

256

1332

1.25

2.95

2.1

2.2

133.0

203.7

ug/l

0.25

246

1271

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

8521

57415

0.96

2.90

3.0

2.9

0.8

ug/l

0.19

5819

37197

(4146454)

559

3140

1.16

2.87

2.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

1261

7451

1.10

2.86

4.6

4.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

170

844

1.31

2.85

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

145

704

1.34

2.83

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

145

704

1.34

2.83

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

145

704

1.34

2.83

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

145

704

1.34

2.83

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

121

571

1.38

2.82

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

205

1.65

2.82

2.0

2.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2376

16554

0.93

2.80

1.6

1.7

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.17

2.78

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

624

0.66

2.78

1.7

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1287

9191

0.91

2.77

2.2

5143.0

4837.0

u/l

0.13

472

3491

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

323

1737

1.21

2.76

1.6

1.4

5.6

6.1

u/l

0.42

285

1446

(3043614) Bacteria identified in Aspirate by Culture

5.70

2.75

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

363

1.47

2.72

1.5

1.6

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.64

2.70

1.1

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

787

4549

1.13

2.68

1.1

10.4

11.7

au/ml

0.26

296

(3047007) Chlamydophila sp Ab [Presence] in Serum

741

4273

1.13

2.63

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

409

1.43

2.62

1.9

2.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

107

1.89

2.62

1.3

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

567

3214

1.15

2.61

1.3

1.5

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

3.91

2.59

2.4

1.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

118

564

1.36

2.58

2.6

2.5

6.9

7.6

mmol/l

1.85

332

(3018291) Platelet Ab [Presence] in Serum

2.48

2.58

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

593

4397

0.88

2.53

3.7

2.7

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

112

533

1.37

2.53

1.8

2.7

3.5

ug/l

0.32

323

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

195

1004

1.27

2.52

1.5

1.4

14.8

14.9

pmol/l

0.11

163

839

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

167

1.68

2.50

4.7

5.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

178

1.65

2.45

1.5

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

377

1.43

2.45

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

140

693

1.32

2.45

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

504

0.65

2.45

2.8

3.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

503

0.65

2.43

5.6

6.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

292

1578

1.21

2.42

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

338

1852

1.19

2.42

1.1

7.5

8.8

iu/ml

0.56

482

(40758292) HTLV I+II Ab panel - Serum

466

1.38

2.40

1.4

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.91

2.39

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

102

1.85

2.35

1.2

1.4

—

(3023410) Appearance of Cerebral spinal fluid

522

2968

1.15

2.34

1.5

1.6

—

(3042517) Benzodiazepines panel - Urine

295

1.48

2.33

2.5

2.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

355

1962

1.18

2.32

2.0

1.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

470

1.37

2.30

1.3

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

627

3614

1.13

2.30

1.1

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

122

1.76

2.30

1.4

1.2

0.1

g/l

0.57

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

193

1558

0.81

2.29

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

667

4873

0.89

2.29

1.1

1.2

1.0

u/ml

0.23

259

1943

(3000285) Sodium [Moles/volume] in Blood

345

1.43

2.28

1.1

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

218

1.55

2.27

4.7

5.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

846

6098

0.90

2.27

1.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

513

2921

1.14

2.27

2.4

2.0

11.2

7.6

umol/l

2.03

397

2102

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

168

1.63

2.22

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1209

7230

1.09

2.21

1.7

1.9

4.6

15.1

iu/l

1.78

426

2668

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

133

665

1.30

2.21

1.2

1.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

194

1.58

2.20

1.1

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

236

1.52

2.18

1.2

1.4

9.9

15.1

pmol/l

0.86

199

(3032352) Blasts [#/volume] in Cerebral spinal fluid

290

1.46

2.15

2.4

2.1

—

(4212803)

243

1.50

2.12

1.0

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

437

2475

1.15

2.12

1.5

1.3

1.4

promille

0.45

340

1912

(3027874) Urate [Moles/volume] in Urine

1.87

2.12

1.2

1.0

1.9

8.3

mmol/l

0.47

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

163

1326

0.80

2.10

2.2

1.7

—

(3050794) Legionella sp Ab [Presence] in Serum

249

1.49

2.10

1.2

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

223

1.52

2.08

3.1

2.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.88

2.07

2.0

2.3

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

213

1.53

2.07

4.6

3.0

2.0

2.2

mg/l

0.28

182

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

3.80

2.06

1.3

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.85

2.05

2.0

2.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

425

2409

1.15

2.05

1.1

—

75.6

titre

—

(3027035) Albumin [Mass/time] in 24 hour Urine

268

1.46

2.00

1.6

1.3

19.6

422.6

mg/24h

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

139

711

1.27

1.98

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

417

2369

1.15

1.96

2.3

711.7

675.7

0.91

294

1604

(3014891) Appearance of Pleural fluid

390

1.37

1.94

1.9

1.6

—

(3020650) Glucose [Presence] in Urine

149

771

1.26

1.94

1.4

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

201

1.52

1.93

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

2.71

1.92

1.0

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.44

1.91

1.1

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

199

1566

0.83

1.90

1.6

1.5

8.2

7.8

mmol/l

0.97

130

936

(3012898) Urea [Moles/volume] in Urine

293

1.42

1.89

1.3

1.5

159.3

170.3

mmol/l

0.35

258

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

354

1.38

1.87

1.0

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

1.86

6.5

5.9

1.2

1.3

mg/l

0.09

(3014599) Egg white IgE Ab [Units/volume] in Serum

227

1760

0.84

1.85

1.1

1.0

0.6

3.5

u/ml

1.03

406

(40768800) Prostate Pathology biopsy report

847

6030

0.91

1.84

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

129

661

1.27

1.84

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

711

5102

0.91

1.82

1.1

4.5

4.4

u/ml

0.04

342

2492

(3013466) aPTT in Blood by Coagulation assay

157

1.58

1.82

1.2

1.1

35.9

37.5

0.45

133

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

378

1.36

1.82

2.3

2.6

0.7

0.5

u/field

0.75

378

(3024869) Neuronal Ab [Presence] in Serum

106

530

1.30

1.82

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5905

37216

1.04

1.82

1.9

1.8

1.5

4.39

5101

32873

(3007916) DNA double strand Ab [Titer] in Serum

373

1.36

1.81

1.6

1.3

192.9

93.8

titre

0.39

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

180

960

1.22

1.81

2.3

1.4

1.0

ug/l

0.83

167

909

(3011985) Renin [Units/volume] in Plasma

693

4084

1.11

1.80

1.4

1.5

60.4

64.6

mu/l

0.20

612

3654

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

107

1.70

1.80

14.5

13.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

138

716

1.26

1.78

8.0

8.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

386

1.35

1.76

1.4

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.73

1.76

1.0

260.3

184.9

pmol/l

0.36

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

187

1005

1.21

1.75

1.1

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1004

6029

1.09

1.75

2.1

2.0

0.9

0.8

nmol/l

4.22

852

5051

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

218

1189

1.19

1.75

2.3

52.1

53.9

umol/l

0.37

168

979

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

159

1.56

1.74

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.76

1.72

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

324

2423

0.87

1.70

1.3

159.1

107.1

pmol/l

0.30

135

781

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

246

1.43

1.67

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

379

2168

1.14

1.67

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

241

1.43

1.66

1.1

1.0

—

(3033942) Copper [Moles/time] in 24 hour Urine

115

1.64

1.65

1.0

1.1

0.3

0.6

umol/24h

0.68

(3028717) Thiamine [Mass/volume] in Blood

307

1.38

1.65

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

479

2783

1.12

1.65

1.1

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

231

1767

0.85

1.65

13.4

12.2

0.6

mmol/l

0.93

216

1616

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

346

1.36

1.65

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

274

2066

0.86

1.63

1.3

1.4

1.5

g/l

0.80

112

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

264

1476

1.17

1.61

5.4

6.1

286.9

3295.3

u/ml

0.80

309

(3025549) Creatine [Moles/time] in 24 hour Urine

232

1.43

1.60

1.5

1.4

—

13.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

15110

100019

0.98

1.60

5.0

4.8

4.0

3.2

ug/l

0.95

13441

90028

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

527

3088

1.11

1.58

1.1

62.9

67.1

au/ml

—

(3011436) Histone Ab [Units/volume] in Serum

117

606

1.26

1.57

1.1

—

39.4

u/ml

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1406

8593

1.07

1.56

1.3

223.2

218.7

miu/ml

0.17

589

3913

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

143

1.55

1.2

1.0

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

123

1.59

1.52

1.1

1.4

0.9

1.2

u/field

0.81

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

385

1.32

1.52

1.1

0.2

0.4

u/ml

0.63

241

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

219

1.43

1.50

1.5

1.6

2.5

2.2

mg/l

0.19

146

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

219

1.43

1.50

1.5

1.6

4.2

3.6

mg/l

0.22

137

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

219

1.43

1.50

1.5

1.6

1.0

1.3

mg/l

0.16

134

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

219

1.43

1.50

1.5

1.6

2.1

2.0

mg/l

0.02

129

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

219

1.43

1.50

1.5

1.6

3.7

2.3

mg/l

0.54

154

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

219

1.43

1.50

1.5

1.6

0.9

1.0

mg/l

0.09

144

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

219

1.43

1.50

1.5

1.6

2.0

1.7

mg/l

0.17

154

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

219

1.43

1.50

1.5

1.6

2.0

2.1

mg/l

0.08

160

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

219

1.43

1.50

1.5

1.6

1.7

2.2

mg/l

0.33

145

(3046861) Legionella sp Ag [Presence] in Urine

155

1.51

1.49

1.1

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

1.79

1.48

5.5

4.6

3.6

4.8

mg/l

0.38

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

104

1.63

1.46

1.2

1.3

—

(3007463) Buprenorphine [Presence] in Urine

104

1.63

1.46

7.3

7.5

—

(4094501)

1357

8306

1.07

1.46

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

226

1.41

1.46

1.5

1.6

1.7

1.8

mg/l

0.07

148

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

646

3844

1.10

1.45

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

657

4664

0.92

1.42

1.1

1.0

1.9

u/ml

2.48

149

1089

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

392

2276

1.12

1.42

1.1

286.1

274.5

mg/l

0.21

349

1998

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

317

0.68

1.41

1.3

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

195

1.44

1.41

1.8

1.6

1.0

0.7

0.35

147

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.17

1.40

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

402

1.30

1.40

1.1

1.2

0.1

8.6

u/ml

1.09

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

802

5639

0.92

1.38

1.1

1.3

1.5

u/ml

0.24

307

2173

(3022670) pH of Venous cord blood

0.00

1.38

0.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.78

1.37

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

642

3833

1.09

1.36

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1190

7275

1.07

1.35

2.4

124.6

110.0

ug/min

0.43

689

4369

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

252

1.37

1.35

2.5

2.4

—

(3006462) Nitrate [Presence] in Urine

244

1379

1.15

1.35

3.6

3.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

314

1.33

1.34

1.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

258

1.36

1.33

2.5

2.4

19.7

22.4

mg/l

0.67

241

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

702

4214

1.09

1.32

1.3

0.2

nmol/l

0.02

269

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.17

1.31

1.1

1.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

355

1.30

1.31

3.0

41.0

41.3

umol/l

0.03

305

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

184

1021

1.17

1.30

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

660

0.79

1.29

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

535

3812

0.91

1.29

1.1

2.5

4.0

u/ml

2.49

214

1509

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

199

1.41

1.29

1.0

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

103

1.58

1.28

1.0

0.3

0.5

u/ml

0.22

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

172

1.44

1.28

1.1

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

109

577

1.23

1.27

3.5

2.6

128.2

100.6

ng/l

0.46

250

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

103

542

1.24

1.27

4.3

4.8

36.0

59.8

u/l

2.15

213

(3015076) Soybean IgE Ab [Units/volume] in Serum

210

1578

0.87

1.27

1.0

0.2

0.8

u/ml

0.91

201

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.63

1.26

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

160

1225

0.85

1.24

3.4

1.7

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

141

1.48

1.23

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

279

1.33

1.23

2.8

2.5

0.5

1.2

mmol/l

5.23

193

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

116

621

1.22

1.3

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

136

1.48

1.22

1.0

1.1

2.0

0.2

u/ml

0.85

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

425

2505

1.11

1.21

1.3

12.5

11.8

mmol/l

0.68

149

701

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

403

2369

1.11

1.21

1.2

1.1

44.1

43.2

mg/l

0.06

344

1981

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

449

0.75

1.21

1.8

1.9

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

169

1.43

1.20

1.2

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

632

3799

1.08

1.18

1.3

1.4

322.3

290.5

pmol/l

0.92

482

2952

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

572

3425

1.09

1.18

1.8

1660.0

3956.3

titre

1.30

152

(4211845)

263

1512

1.13

1.17

3.5

2.9

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

163

1238

0.86

1.16

1.7

1.8

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

463

3300

0.91

1.16

1.1

1.0

0.4

0.5

u/ml

0.41

102

690

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

698

4221

1.08

1.14

1.3

0.6

1.5

nmol/l

1.36

667

4074

(3038071) Oxygen [Partial pressure] in Mixed venous blood

116

628

1.20

1.12

8.0

8.4

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

1.61

1.12

2.4

2.2

0.1

ug/l

0.26

(3020491) Glucose [Moles/volume] in Blood

374

2202

1.11

1.12

1.8

7.2

6.9

mmol/l

1.08

262

1577

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

285

1653

1.12

1.0

1.1

u/l

0.18

126

759

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

365

1.27

1.10

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

217

1.35

1.09

1.1

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

412

1.25

1.09

1.6

1.3

54.1

51.0

0.20

194

(3036071) Salmonella sp Ab [Titer] in Serum

164

919

1.16

1.07

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

218

1.34

1.07

1.1

12.6

9.7

u/l

0.32

218

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

207

1.35

1.06

1.1

—

(3036180) Methadone [Presence] in Urine

1.80

1.06

2.8

2.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

2312

15625

0.96

1.06

1.4

1.3

31.6

29.9

iu/l

1.53

2002

13600

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

163

1.40

1.05

1.1

41.2

90.3

u/l

0.63

125

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

270

1570

1.12

1.03

1.3

5.8

mmol/l

0.13

255

1475

(4027681)

310

1817

1.11

1.03

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

121

664

1.19

1.03

1.1

—

(44813793)

353

2084

1.10

1.03

1.1

—

(37019676) Renin [Units/volume] in Plasma --supine

1.65

1.00

1.0

26.3

67.4

mu/l

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

1.00

0.0

1.1

—

69.8

—

(3051101) Glucose [Moles/volume] in Cord blood

550

0.80

0.99

4.6

5.7

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

227

1.32

0.99

1.0

0.0

0.2

u/ml

1.20

123

(40763791) Oxygen content in Venous blood by calculation

1.58

0.97

7.8

6.1

12.4

12.3

ml/dl

0.05

(3041184) Isoniazid [Presence] in Urine

1.83

0.97

2.3

2.6

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

1.98

0.96

1.3

1.1

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.98

0.96

1.4

3.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.49

0.96

1.0

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.52

0.96

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

577

4035

0.93

0.96

1.1

3.6

3.9

u/ml

0.11

216

1513

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.63

0.96

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

139

778

1.16

0.96

1.5

1.8

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

258

1.29

0.93

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

371

2212

1.09

0.91

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

268

1574

1.11

0.90

1.3

1.7

—

(3036005) Urine sediment comments by Light microscopy Narrative

1.93

0.89

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

654

3991

1.07

0.89

1.3

7.3

mmol/l

0.00

487

2889

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

108

1.45

0.89

1.0

0.4

0.3

u/ml

0.13

(40763590) HLA-DQ beta [Type]

108

1.45

0.89

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

293

1730

1.10

0.89

1.1

8.5

4.7

nmol/l

0.27

337

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.54

0.88

3.5

3.2

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

221

1.30

0.86

1.8

1.4

37.9

0.00

150

(37021550) Renin [Units/volume] in Plasma --upright

112

623

1.17

0.86

1.2

1.3

59.7

68.2

mu/l

0.15

471

(3001729) Color of Synovial fluid

233

1.29

0.85

1.8

1.5

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

193

1.32

0.85

1.9

1.4

11.2

12.7

0.26

140

(3013247) Albumin in CSF/Albumin in Serum or Plasma

113

630

1.17

0.85

1.1

6.6

7.2

mg/g

0.63

107

593

(3020618) Glucose [Moles/volume] in Synovial fluid

104

1.44

0.84

1.1

1.0

5.9

5.3

mmol/l

0.31

(40758358) Immune stain study

126

1.40

0.84

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

205

1.30

0.84

1.2

1.1

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.54

0.83

1.0

859.8

205.6

u/l

0.84

(3045683) HLA typing for celiac disease panel - Blood or Tissue

251

1804

0.91

0.83

1.0

—

(40760409) HLA-A [Type] by High resolution

110

1.42

0.82

1.0

—

(40760410) HLA-B [Type] by High resolution

110

1.42

0.82

1.0

—

(46236302) HLA-C [Type] by High resolution typing

110

1.42

0.82

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

235

1.27

0.81

1.0

0.0

1.9

u/ml

0.68

128

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

100

0.59

0.81

1.1

1.0

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

161

1.33

0.80

1.0

1.1

0.0

1.2

u/ml

2.15

111

(3013862) HLA-DP [Type]

111

1.41

0.79

1.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

472

1.19

0.79

1.8

1.7

35.0

63.4

pmol/l

1.69

393

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1307

8865

0.96

0.78

1.7

42.4

41.5

nmol/l

0.75

1263

8639

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3448

23002

0.97

0.77

2.3

2.2

12.1

12.6

nmol/l

2.72

2999

20468

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

382

2302

1.08

0.77

1.9

2.0

17.6

17.8

nmol/l

0.15

355

2177

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

180

1.30

0.75

1.5

1.3

16.6

17.3

pmol/l

0.08

151

(3003694) ABO and Rh group [Type] in Blood

12553

80789

1.01

0.74

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

607

0.85

0.74

3.2

2.9

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

315

1.22

0.73

1.1

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

2.03

0.73

1.0

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

164

1.31

0.72

1.1

2.6

3.1

u/l

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

350

0.80

0.72

1.3

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

808

5004

1.05

0.72

1.2

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

328

1.21

0.71

1.1

1.2

—

1.8

mmol/l

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

394

1.19

0.70

1.3

0.2

0.3

nmol/l

1.11

271

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

217

1.26

0.70

1.0

0.1

0.6

u/ml

1.44

120

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

1.42

0.69

1.0

0.3

0.4

u/ml

0.28

(3020874) Milk IgE Ab [Units/volume] in Serum

248

1763

0.92

0.69

1.0

1.1

2.1

2.6

u/ml

0.11

481

(3007700) Barley IgE Ab [Units/volume] in Serum

120

1.36

0.69

1.0

1.2

0.3

u/ml

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.67

0.68

1.0

1.1

1448.0

2144.6

titre

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

173

1013

1.11

0.67

3.1

7.7

7.9

mg/l

0.14

145

793

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1642

11045

0.97

0.67

1.8

1.7

3.5

3.6

mg/l

0.06

1235

7808

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.40

0.66

1.0

0.1

0.3

u/ml

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

124

713

1.13

0.66

1.2

275.1

303.5

pmol/l

0.41

530

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

167

1.29

0.65

1.7

1.3

0.6

1.8

1.87

112

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

290

1.21

0.65

1.1

1.9

1.7

umol/24h

0.37

290

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

308

0.80

0.64

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

168

1.28

0.63

1.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

159

932

1.11

0.62

2.5

2.6

171.5

151.6

au/ml

0.17

126

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.62

0.0

1.3

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

1.71

0.62

1.0

1.5

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

1.71

0.62

1.2

27.4

29.3

nmol/24h

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.51

0.62

1.5

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

117

1.34

0.62

1.0

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.0

—

2.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

652

4458

0.95

0.61

1.4

1.3

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.58

0.61

1.3

1.2

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.40

0.60

2.8

1.3

79.7

139.8

ug/l

1.69

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

628

0.87

0.59

1.2

1.1

62.9

63.2

u/ml

0.01

613

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

122

890

0.89

0.59

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

151

886

1.11

0.59

1.2

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

217

1.23

0.58

1.2

26.5

24.8

0.05

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

226

1354

1.09

0.58

1.5

1.6

3.7

8.9

nmol/l

0.65

181

1142

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

382

0.83

0.58

3.0

2.3

—

(3018133) Calcium [Moles/volume] in Urine

415

1.16

0.58

1.8

1.7

2.2

2.7

mmol/l

1.74

371

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

159

1.27

0.57

1.0

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

1.70

0.57

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

145

851

1.11

0.57

1.2

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

333

1.17

0.54

1.1

1.2

—

1.0

mmol/l

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

126

1.29

0.53

1.2

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.56

0.53

1.0

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

469

0.86

0.53

1.0

92.4

82.3

ug/l

0.83

376

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

392

0.85

0.53

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

193

1155

1.09

0.53

1.9

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

203

1218

1.09

0.52

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.42

0.52

4.7

5.6

0.2

0.3

mmol/l

0.34

(3001556) Androgen free Index in Serum or Plasma

228

0.80

0.52

1.8

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.37

0.52

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

184

0.78

0.51

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.43

0.51

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

5025

33190

0.98

0.50

1.6

1.7

—

(3011048) Pyruvate [Moles/volume] in Blood

145

1.26

0.50

1.2

1.4

73.2

81.7

umol/l

0.63

137

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

118

692

1.11

0.50

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

193

1.21

0.48

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

199

1199

1.08

0.48

1.1

787.2

404.1

ng/l

0.43

270

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

217

1.20

0.48

1.7

3.1

44.8

357.7

pmol/l

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.33

0.48

1.2

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1599

10142

1.03

0.47

1.4

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.46

0.47

1.0

0.1

1.4

u/ml

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

296

1.17

0.47

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

694

4698

0.96

0.47

1.1

325.6

3208.5

iu/ml

0.68

143

984

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

100

1.30

0.46

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

130

0.75

0.45

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1538

9759

1.03

0.45

1.5

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

159

1.23

0.45

1.0

—

(3045177) Copper [Moles/volume] in Urine

1.48

0.45

1.0

1.1

0.5

umol/l

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

261

1.17

0.45

1.0

0.1

0.2

u/ml

0.90

159

(3009214) Lutropin [Units/volume] in Serum or Plasma

1238

8287

0.97

0.44

1.4

11.8

10.6

u/l

2.00

997

6798

(40762887) Creatinine [Moles/volume] in Blood

1.39

0.44

1.1

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.43

0.43

1.2

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

172

1.21

0.43

1.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

172

1.21

0.43

1.2

1.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

532

1.11

0.43

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

532

1.11

0.43

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

354

1.14

0.42

1.6

2.0

8.0

7.0

mmol/l

1.18

126

(3009992) Blasts/100 cells in Bone marrow

1.55

0.42

2.0

1.6

16.4

21.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

263

1.16

0.42

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

282

1944

0.94

0.42

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

683

0.91

0.41

1.5

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

644

4349

0.96

0.41

1.4

0.4

nmol/l

0.11

479

3323

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.34

0.40

3.4

3.5

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

132

1.23

0.40

1.0

1.1

6.7

5.1

u/ml

0.12

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

468

3178

0.96

0.39

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

698

4390

1.04

0.39

5.1

356.5

367.4

umol/l

1.04

597

3805

(4133840)

144

868

1.08

0.38

1.1

1.2

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

163

1.20

0.38

1.2

1.6

0.8

0.7

umol/l

0.41

121

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

550

1.10

0.37

2.0

1.9

16.1

16.8

umol/l

0.29

550

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

532

1.10

0.37

1.2

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.39

0.35

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

368

0.88

0.34

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

135

1.21

0.34

1.0

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.69

0.34

1.0

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

263

1.14

0.33

1.0

8.1

4.0

u/ml

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

208

1.16

0.33

3.3

4.7

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

160

1.18

0.32

3.2

3.6

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

118

1.21

0.32

1.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.38

0.32

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

238

1473

1.05

0.31

1.3

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.36

0.31

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.30

0.31

1.1

1.0

132.0

142.1

mmol/24h

—

(3013762) Body weight Measured

107

1.22

0.30

1.2

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

506

0.91

0.29

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

161

988

1.06

0.29

2.1

1.9

8.0

9.3

mg/l

2.86

130

789

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

199

1.14

0.28

1.0

1.3

—

(36303858) Crystals [Presence] in Urine

1.30

0.28

1.1

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.30

0.28

1.6

1.3

—

(3024316) Viscosity of Plasma

155

0.84

0.27

1.5

1.8

1.5

1.7

mpas

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.30

0.27

1.2

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

151

1.16

0.27

1.1

1.0

0.1

0.4

u/ml

1.30

136

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

361

1.10

0.27

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

127

776

1.07

0.27

1.2

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

180

1112

1.05

0.27

2.9

28.6

umol/l

0.00

146

848

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

127

1.18

0.26

11.8

8.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

208

1291

1.05

0.26

1.1

1596.3

1521.6

miu/ml

0.45

208

1291

(3016031) Almond IgE Ab [Units/volume] in Serum

168

0.85

0.26

1.1

1.0

0.4

u/ml

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

112

0.81

0.26

1.3

1.1

358.4

261.0

nmol/l

0.62

112

(1002224) Polysomnography panel

2009

13266

0.99

0.26

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

111

771

0.94

0.26

1.0

1.1

0.7

2.9

u/ml

1.16

415

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.72

0.24

1.0

1.1

71.0

99.3

nmol/24h

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.20

0.24

1.2

1.4

504.1

487.4

nmol/l

0.05

(3027974) Hepatitis B virus e Ag [Presence] in Serum

184

1.13

0.23

1.2

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

113

781

0.94

0.23

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

337

0.91

0.23

1.1

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.79

0.23

1.0

1.1

274.2

387.5

pmol/l

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.75

0.23

1.3

1.4

1.6

2.2

mmol/24h

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

148

916

1.05

0.22

1.4

1.5

74.0

72.4

0.64

140

869

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

391

1.08

0.22

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.28

0.22

1.0

1.1

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.21

0.22

1.0

1.2

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.22

0.0

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.22

0.0

1.0

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.22

0.0

5.9

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

281

0.90

0.22

7.4

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

136

1.15

0.21

1.0

17.5

15.8

u/ml

0.07

107

(3041672) Baker's yeast Ab [Presence] in Serum

130

0.85

0.21

1.0

1.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.21

0.0

1.0

—

161.7

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

196

1329

0.96

0.21

1.4

1.3

3.7

4.3

umol/l

1.98

175

1219

(3028679) Herpes simplex virus Ab [Presence] in Serum

240

1506

1.04

0.21

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

292

1.09

0.21

2.3

2.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

112

770

0.95

0.21

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

661

4212

1.02

0.21

2.9

2.6

13.3

13.2

1.56

656

4153

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

164

0.87

0.20

1.0

1.1

17.5

20.9

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

164

0.87

0.20

1.0

1.1

28.6

30.1

u/ml

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

236

1.10

0.20

1.1

1.0

0.2

2.0

u/ml

1.03

169

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

318

1.08

0.20

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

197

1333

0.96

0.20

1.2

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

132

819

1.05

0.19

1.0

1.1

9.9

9.5

u/ml

0.04

117

(3034092) Cytoplasmic Ig cells/100 cells in Blood

382

1.07

0.19

8.8

8.3

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.17

0.18

5.4

2.2

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

207

1.10

0.18

1.2

1.1

14.6

14.8

nmol/l

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.14

0.17

1.1

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.71

0.17

1.0

4.4

9.1

u/ml

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.21

0.17

2.1

2.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

102

1.15

0.17

3.1

2.0

4.4

4.3

mmol/l

0.48

(3025130) Human papilloma virus identified in Specimen

616

4084

0.98

0.16

1.6

1.7

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.85

0.16

1.6

1.2

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.17

0.15

1.1

1.0

0.2

0.0

u/ml

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

144

903

1.04

0.15

1.4

1.5

474.1

795.1

mu/l

1.46

136

856

(3010937) Rubella virus Ab [Presence] in Serum

153

1.11

0.15

1.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.81

0.14

1.4

1.1

1.3

2.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

303

1927

1.02

0.14

1.0

42.3

41.8

ng/l

0.07

201

1365

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.85

0.14

1.7

2.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

388

1.06

0.13

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

192

1.08

0.13

1.0

0.2

u/ml

0.16

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

414

1.05

0.13

1.0

1.1

0.4

3.9

u/ml

1.32

292

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

832

5484

0.99

0.13

1.7

1.6

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

440

1.05

0.13

1.1

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

142

1.10

0.12

1.3

1.7

mg/l

0.05

117

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

161

1.09

0.12

1.0

0.1

1.3

u/ml

0.90

121

(3000034) Microalbumin [Mass/volume] in Urine

419

2774

0.98

0.12

3.3

2.9

55.6

51.6

mg/l

0.12

292

1984

(3015183) Erythrocyte sedimentation rate

245

1559

1.02

0.12

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

152

1019

0.97

0.12

2.3

2.5

162.1

151.8

nmol/l

0.46

131

885

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

441

2826

1.02

0.11

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

118

1.10

0.11

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.12

0.10

1.0

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

970

6375

0.99

0.10

2.0

1.9

192.6

198.3

pmol/l

1.06

920

6036

(3009754) Celery IgE Ab [Units/volume] in Serum

1.16

0.10

1.0

0.0

0.2

u/ml

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.16

0.10

3.6

2.0

2.9

2.1

mu/l

—

(44806420)

126

797

1.03

0.10

2.4

2.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.08

0.09

1.0

1.4

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.08

0.09

1.0

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

301

1926

1.02

0.09

1.0

770.7

742.4

ng/l

0.47

186

1349

(3030313) Adrenal Ab [Titer] in Serum

253

1.05

0.09

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

314

0.95

0.08

1.3

1.7

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

1.14

0.08

1.1

1.3

—

1402.8

umol/l

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.03

0.08

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.03

0.08

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.03

0.08

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.03

0.08

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.03

0.08

2.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.03

0.08

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.03

0.08

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.08

0.08

1.1

1.2

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

154

0.93

0.08

1.0

0.2

1.0

u/ml

0.63

101

(4038314)

133

1.08

0.08

1.3

1.2

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.86

0.07

1.0

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.88

0.07

1.6

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

652

4279

0.99

0.06

1.1

3.1

3.0

u/ml

0.03

260

2126

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.10

0.06

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

243

1.04

0.06

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

417

1.03

0.06

1.2

1.1

—

(3003577) Lead [Moles/volume] in Blood

231

0.96

0.05

1.5

1.4

0.1

0.2

umol/l

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

494

0.98

0.05

5.6

7.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

758

4904

1.01

0.05

1.3

1.4

31.5

28.9

u/l

1.20

615

4012

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

126

806

1.02

0.05

1.7

1.6

117.3

137.1

au/ml

0.19

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

109

723

0.98

0.05

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

277

1821

0.99

0.04

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

297

1917

1.01

0.04

1.0

345.2

331.0

ng/l

0.17

197

1386

(3020356) Listeria sp identified in Specimen by Organism specific culture

137

0.95

0.03

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

183

0.96

0.03

1.6

1.4

22.7

22.5

mmol/l

0.11

124

(3034614) HLA Ag [Interpretation]

0.92

0.03

1.4

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

718

4695

1.00

0.03

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

347

0.98

0.03

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

717

4688

1.00

0.03

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

143

1.05

0.03

1.6

1.5

0.4

0.1

u/l

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

327

0.98

0.03

1.8

1.7

1.9

1.7

mg/l

0.50

269

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

428

1.02

0.03

1.2

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

502

3281

1.00

0.02

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

319

0.98

0.02

1.0

1.1

—

(4198724)

187

1209

1.01

0.02

3.2

2.1

—

(3003338) MCHC [Mass/volume]

39526

257259

1.00

0.01

23.9

17.0

331.3

332.7

g/l

160.38

39209

255241

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

311

0.98

0.01

1.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.94

0.01

1.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

237

1.02

0.00

1.0

0.0

2.6

u/ml

0.66

171

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.98

0.00

5.3

9.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

192

1.02

0.00

1.4

318.0

338.1

umol/24h

0.18

192

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.98

0.00

1.5

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

162

1.00

0.00

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

517

0.99

0.00

1.5

1.6

—

(3022689) Creatine [Moles/volume] in Urine

131

856

1.00

0.00

1.5

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

222

1445

1.00

0.00

2.1

280.1

77.3

ug/min

0.97

324

(3022475) Manganese [Moles/volume] in Blood

192

0.98

0.00

1.4

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

109

1.02

0.00

1.2

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

244

1.01

0.00

1.4

1.6

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.97

0.00

1.2

1.1

—

mmol/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

118

771

1.00

0.00

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

404

1.00

0.00

2.9

2.6

61.8

64.1

pmol/l

0.09

352

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

119

776

1.00

0.00

1.1

—

(3045191) Normetanephrine [Moles/volume] in Urine

0.00

0.0

1.2

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.98

0.00

2.6

4.2

—

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3003157) Bacteria [#/volume] in Mother's milk

0.83

0.00

2.6

7.5

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.90

0.00

1.4

1.2

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.98

0.00

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.93

0.00

2.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_DISVEINLYMPH and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_DISVEINLYMPH	1.607 [1.48, 1.75]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.087

During the follow-up period (1.1.1998 — 31.12.2019), 31662 out of 161649 females with I9_DISVEINLYMPH died.

Males

Parameter	HR [95% CI]	p-value
I9_DISVEINLYMPH	1.762 [1.61, 1.92]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 27955 out of 106317 males with I9_DISVEINLYMPH died.

Mortality risk

Mortality risk for people of age

years, who have I9_DISVEINLYMPH.

N-year risk	Females	Males
1	0.183%	0.277%
5	0.831%	1.788%
10	2.054%	4.524%
15	4.137%	8.515%
20	7.098%	13.951%

Relationships between endpoints

↥

Index endpoint: I9_DISVEINLYMPH – Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

GWS hits: 193

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints